
<html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="utf-8"/></head><body><article xmlns="" data-html-name="article" data-standard-html-version="1.0" data-name="OPT_ID_1" data-attr-article-type="research-article" data-attr-data-query-meta-info="comment-text" data-attr-dtd-version="1.1" data-attr-xml_lang="EN" data-para="true"><div class="extended1" id="extended1"></div><div data-html-name="floats"></div><section data-html-name="body" data-name="OPT_ID_200" data-para="true" id="body"><section data-html-name="head" data-name="OPT_ID_2" data-para="true"><div data-html-name="journal-metadata" data-standard-html-version="1.0" data-name="OPT_ID_3" data-para="true"><div data-html-name="journal-id" data-name="OPT_ID_4" data-attr-journal-id-type="hwp" data-para="true">bloodjournal</div><div data-html-name="journal-id" data-name="OPT_ID_5" data-attr-journal-id-type="pmc" data-para="true">blood</div><div data-html-name="journal-id" data-name="OPT_ID_6" data-attr-journal-id-type="publisher-id" data-para="true">Blood</div><div data-html-name="journal-title" data-name="OPT_ID_8" data-para="true">Blood, The Journal of the American Society of Hematology</div><div data-html-name="journal-abbrev" data-name="OPT_ID_9" data-attr-abbrev-type="full" data-para="true">Blood</div><div data-html-name="issn" data-name="OPT_ID_10" data-attr-pub-type="ppub" data-para="true">0006-4971</div><div data-html-name="issn" data-name="OPT_ID_11" data-attr-pub-type="epub" data-para="true">1528-0020</div><div data-html-name="publisher-name" data-name="OPT_ID_13" data-para="true">American Society of Hematology</div><div data-html-name="publisher-loc" data-name="OPT_ID_14" data-para="true">Washington, DC</div><div data-html-name="journal-id" data-attr-journal-id-type="nlm-ta"></div><div data-html-name="journal-abbrev" data-attr-abbrev-type="pubmed"></div><div data-html-name="journal-abbrev" data-abbrev-type="default"></div></div><div data-html-name="article-meta" data-standard-html-version="1.0" data-name="OPT_ID_15" data-para="true"><div data-html-name="article-metadata"><div data-html-name="article-id" data-name="OPT_ID_16" data-attr-pub-id-type="publisher-id" data-para="true">2017/786947</div><div data-html-name="article-id" data-name="OPT_ID_17" data-attr-pub-id-type="doi" data-para="true">10.1182/blood-2017-05-786947</div><div data-html-name="subj-group" data-name="OPT_ID_19" data-attr-subj-group-type="heading" data-para="true"><div data-html-name="subject-area" data-name="OPT_ID_19" data-attr-subj-group-type="heading" data-para="true">Regular Article</div></div><div data-html-name="subj-group" data-name="OPT_ID_21" data-attr-subj-group-type="leader" data-para="true"><div data-html-name="subject-area" data-name="OPT_ID_21" data-attr-subj-group-type="leader" data-para="true">Lymphoid Neoplasia</div></div><div data-html-name="pub-date" data-name="OPT_ID_157" data-attr-pub-type="ppub" data-para="true"><span data-html-name="day" data-name="OPT_ID_158">00</span><span data-html-name="month" data-name="OPT_ID_159">00</span><span data-html-name="year" data-name="OPT_ID_160">2018</span></div><div data-html-name="pub-date" data-name="OPT_ID_161" data-attr-pub-type="epreprint" data-para="true"><span data-html-name="day" data-name="OPT_ID_162">09</span><span data-html-name="month" data-name="OPT_ID_163">01</span><span data-html-name="year" data-name="OPT_ID_164">2018</span></div><div data-html-name="volume" data-name="OPT_ID_165" data-para="true">00</div><div data-html-name="issue" data-name="OPT_ID_166" data-para="true">00</div><div data-html-name="first-page" data-name="OPT_ID_167" data-para="true">00</div><div data-html-name="last-page" data-name="OPT_ID_168" data-para="true">00</div><div data-html-name="received-date" data-name="OPT_ID_170" data-attr-date-type="received" data-para="true"><span data-html-name="day" data-name="OPT_ID_171">25</span><span data-html-name="month" data-name="OPT_ID_172">05</span><span data-html-name="year" data-name="OPT_ID_173">2017</span></div><div data-html-name="accepted-date" data-name="OPT_ID_174" data-attr-date-type="accepted" data-para="true"><span data-html-name="day" data-name="OPT_ID_175">01</span><span data-html-name="month" data-name="OPT_ID_176">01</span><span data-html-name="year" data-name="OPT_ID_177">2018</span></div><div data-html-name="permissions" data-name="OPT_ID_178" data-para="true"><span data-html-name="copyright-statement" data-name="OPT_ID_179"><span data-html-name="unicode-char">©</span> 2018 by The American Society of Hematology</span><span data-html-name="copyright-year" data-name="OPT_ID_180">2018</span><span data-html-name="copyright-holder"></span><span data-html-name="license-type"><span data-license-type=""></span><span data-html-name="license-text"></span></span></div><div data-html-name="article-uri" data-name="OPT_ID_181" data-attr-xlink_title="pdf" data-para="true" data-attr-xlink-href="blood-2017-05-786947.pdf"></div><div data-html-name="article-uri" data-name="OPT_ID_182" data-attr-xlink_role="icon" data-para="true" data-attr-xlink-href="blood786947_thumb.jpg"></div><div data-html-name="counts" data-name="OPT_ID_198" data-para="true"><div data-html-name="page-count" data-name="OPT_ID_199">0</div><div data-html-name="figure-count"></div><div data-html-name="table-count"></div><div data-html-name="equation-count"></div><div data-html-name="reference-count"></div><div data-html-name="word-count"></div></div><div data-html-name="article-type-group"><div data-html-name="article-type"></div><div data-html-name="article-sub-type"></div></div><div data-html-name="collection-code-group"><div data-html-name="collection-code"></div></div><div data-html-name="series-title"></div><div data-html-name="pub-date" data-attr-pub-type="epub"><span data-html-name="day"></span><span data-html-name="month"></span><span data-html-name="year"></span></div><div data-html-name="revised-date" data-attr-date-type="revised"><span data-html-name="day"></span><span data-html-name="month"></span><span data-html-name="year"></span></div><a data-html-name="link" data-type="related-article" href="" data-related-article-type=""></a><div data-html-name="elocation-id"></div><div data-html-name="custom-meta"><div data-html-name="meta-name"></div><div data-html-name="meta-value"></div></div></div><div data-html-name="right-running-head" data-name="OPT_ID_05" data-para="true"><span data-auto-generated="true">Short title: </span>CK1 AS A THERAPEUTIC TARGET IN MURINE CLL MODEL</div><h1 data-html-name="article-title" data-name="OPT_ID_24" data-para="true">Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia</h1><div data-html-name="contrib-group" data-standard-html-version="1.0" data-name="OPT_ID_25" data-para="true"><span data-html-name="contrib-author" data-name="OPT_ID_26" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_28">Janovska</span><span data-html-name="given-name" data-name="OPT_ID_29">Pavlina</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_30"><span data-history="original" data-attr-rid="aff1">1</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_31" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_33">Verner</span><span data-html-name="given-name" data-name="OPT_ID_34">Jan</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_35"><span data-history="original" data-attr-rid="aff2">2</span></cite><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_36"><span data-history="original" data-attr-rid="aff3">3</span></cite><cite data-standard-html-version="1.0" data-html-name="fn" data-attr-ref-type="fn" data-name="OPT_ID_37"><span data-history="original" data-attr-rid="fn1">*</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_38" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_40">Kohoutek</span><span data-html-name="given-name" data-name="OPT_ID_41">Jiri</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_42"><span data-history="original" data-attr-rid="aff4">4</span></cite><cite data-standard-html-version="1.0" data-html-name="fn" data-attr-ref-type="fn" data-name="OPT_ID_43"><span data-history="original" data-attr-rid="fn1">*</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_44" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_46">Bryjova</span><span data-html-name="given-name" data-name="OPT_ID_47">Lenka</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_48"><span data-history="original" data-attr-rid="aff1">1</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_49" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_51">Gregorova</span><span data-html-name="given-name" data-name="OPT_ID_52">Michaela</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_53"><span data-history="original" data-attr-rid="aff1">1</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_54" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_56">Dzimkova</span><span data-html-name="given-name" data-name="OPT_ID_57">Marta</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_58"><span data-history="original" data-attr-rid="aff4">4</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_59" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_61">Skabrahova</span><span data-html-name="given-name" data-name="OPT_ID_62">Hana</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_63"><span data-history="original" data-attr-rid="aff2">2</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_64" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_66">Radaszkiewicz</span><span data-html-name="given-name" data-name="OPT_ID_67">Tomasz</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_68"><span data-history="original" data-attr-rid="aff1">1</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_69" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_71">Ovesna</span><span data-html-name="given-name" data-name="OPT_ID_72">Petra</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_73"><span data-history="original" data-attr-rid="aff5">5</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_74" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_76">Blanarova</span><span data-html-name="given-name" data-name="OPT_ID_77">Olga Vondalova</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_78"><span data-history="original" data-attr-rid="aff1">1</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_79" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_81">Nemcova</span><span data-html-name="given-name" data-name="OPT_ID_82">Tereza</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_83"><span data-history="original" data-attr-rid="aff1">1</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_84" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_86">Hoferova</span><span data-html-name="given-name" data-name="OPT_ID_87">Zuzana</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_88"><span data-history="original" data-attr-rid="aff6">6</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_89" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_91">Vasickova</span><span data-html-name="given-name" data-name="OPT_ID_92">Katerina</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_93"><span data-history="original" data-attr-rid="aff7">7</span></cite><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_94"><span data-history="original" data-attr-rid="aff8">8</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_95" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_97">Smyckova</span><span data-html-name="given-name" data-name="OPT_ID_98">Lucie</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_99"><span data-history="original" data-attr-rid="aff1">1</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_100" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_102">Egle</span><span data-html-name="given-name" data-name="OPT_ID_103">Alexander</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_104"><span data-history="original" data-attr-rid="aff9">9</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_105" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_107">Pavlova</span><span data-html-name="given-name" data-name="OPT_ID_108">Sarka</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_109"><span data-history="original" data-attr-rid="aff2">2</span></cite><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_110"><span data-history="original" data-attr-rid="aff3">3</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_111" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_113">Poppova</span><span data-html-name="given-name" data-name="OPT_ID_114">Lucie</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_115"><span data-history="original" data-attr-rid="aff2">2</span></cite><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_116"><span data-history="original" data-attr-rid="aff3">3</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_117" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_119">Plevova</span><span data-html-name="given-name" data-name="OPT_ID_120">Karla</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_121"><span data-history="original" data-attr-rid="aff2">2</span></cite><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_122"><span data-history="original" data-attr-rid="aff3">3</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_123" data-attr-parent-contrib-type="author"><span data-html-name="surname" data-name="OPT_ID_125">Pospisilova</span><span data-html-name="given-name" data-name="OPT_ID_126">Sarka</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_127"><span data-history="original" data-attr-rid="aff2">2</span></cite><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_128"><span data-history="original" data-attr-rid="aff3">3</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><span data-html-name="contrib-author" data-name="OPT_ID_129" data-attr-parent-contrib-type="author" data-attr-parent-corresp="yes" data-attr-corresp="yes"><span data-html-name="surname" data-name="OPT_ID_131">Bryja</span><span data-html-name="given-name" data-name="OPT_ID_132">Vitezslav</span><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_133"><span data-history="original" data-attr-rid="aff1">1</span></cite><cite data-standard-html-version="1.0" data-html-name="aff" data-attr-ref-type="aff" data-name="OPT_ID_134"><span data-history="original" data-attr-rid="aff6">6</span></cite><span data-html-name="degrees"></span><span data-html-name="orcid"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span><span data-html-name="roles"></span></span><div data-html-name="affiliation" data-name="OPT_ID_135" data-attr-id="aff1" data-para="true"><span data-html-name="aff-label" data-name="OPT_ID_136" data-para="true">1</span><span data-html-name="unstructured-aff"><span data-html-name="unknown">Institute of Experimental Biology, Faculty of Science, </span></span></div><div data-html-name="affiliation" data-name="OPT_ID_137" data-attr-id="aff2" data-para="true"><span data-html-name="aff-label" data-name="OPT_ID_138" data-para="true">2</span><span data-html-name="unstructured-aff"><span data-html-name="unknown">Center of Molecular Biology and Gene Therapy, Department of Internal Medicine<span data-html-name="unicode-char">–</span>Hematology and Oncology, University Hospital Brno and Medical Faculty, and </span></span></div><div data-html-name="affiliation" data-name="OPT_ID_139" data-attr-id="aff3" data-para="true"><span data-html-name="aff-label" data-name="OPT_ID_140" data-para="true">3</span><span data-html-name="unstructured-aff"><span data-html-name="unknown">Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic; </span></span></div><div data-html-name="affiliation" data-name="OPT_ID_141" data-attr-id="aff4" data-para="true"><span data-html-name="aff-label" data-name="OPT_ID_142" data-para="true">4</span><span data-html-name="unstructured-aff"><span data-html-name="unknown">Department of Chemistry and Toxicology, Veterinary Research Institute, Brno, Czech Republic; </span></span></div><div data-html-name="affiliation" data-name="OPT_ID_143" data-attr-id="aff5" data-para="true"><span data-html-name="aff-label" data-name="OPT_ID_144" data-para="true">5</span><span data-html-name="unstructured-aff"><span data-html-name="unknown">Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic; </span></span></div><div data-html-name="affiliation" data-name="OPT_ID_145" data-attr-id="aff6" data-para="true"><span data-html-name="aff-label" data-name="OPT_ID_146" data-para="true">6</span><span data-html-name="unstructured-aff"><span data-html-name="unknown">Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic; </span></span></div><div data-html-name="affiliation" data-name="OPT_ID_147" data-attr-id="aff7" data-para="true"><span data-html-name="aff-label" data-name="OPT_ID_148" data-para="true">7</span><span data-html-name="unstructured-aff"><span data-html-name="unknown">International Clinical Research Center, Center for Biomolecular and Cellular Engineering, St. Anne<span data-html-name="unicode-char">’</span>s University Hospital in Brno, Brno, Czech Republic; </span></span></div><div data-html-name="affiliation" data-name="OPT_ID_149" data-attr-id="aff8" data-para="true"><span data-html-name="aff-label" data-name="OPT_ID_150" data-para="true">8</span><span data-html-name="unstructured-aff"><span data-html-name="unknown">Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; and </span></span></div><div data-html-name="affiliation" data-name="OPT_ID_151" data-attr-id="aff9" data-para="true"><span data-html-name="aff-label" data-name="OPT_ID_152" data-para="true">9</span><span data-html-name="unstructured-aff"><span data-html-name="unknown">Paracelsus Medical University, Salzburg, Austria</span></span></div><address data-html-name="corresp" data-name="OPT_ID_1037" data-para="true" data-from="paragraph"><span data-html-name="unknown">Correspondence: V<span data-html-name="unicode-char">í</span>t<span data-html-name="unicode-char">ě</span>zslav Bryja, Institute of Experimental Biology, Faculty of Science, Masaryk University, Kotl<span data-html-name="unicode-char">á</span><span data-html-name="unicode-char">ř</span>sk<span data-html-name="unicode-char">á</span> 2, 611 37 Brno, Czech Republic; e-mail: </span><a data-html-name="email" href="mailto:bryja@sci.muni.cz" data-name="OPT_ID_1038">bryja@sci.muni.cz</a><span data-html-name="unknown">.</span></address><div data-html-name="author-footnote" data-name="OPT_ID_153" data-para="true"><div data-html-name="contrib-fn" data-name="OPT_ID_154" data-attr-fn-type="equal" data-attr-id="fn1" data-para="true"><span data-html-name="fn-label" data-name="OPT_ID_155" data-para="true">*</span><span data-html-name="para" data-name="OPT_ID_156" data-para="true">J.V. and J.K. contributed equally to this study.</span></div></div></div><div data-html-name="abstract" data-name="OPT_ID_183" data-attr-abstract-type="executive-summary" data-para="true"><h2 data-html-name="section-title" aria-level="2" data-name="OPT_ID_184" data-para="true">Key Points</h2><div data-html-name="para" data-name="OPT_ID_185" data-para="true"><ul data-html-name="list" data-name="OPT_ID_186" data-attr-list-type="bullet" data-para="true"><li data-html-name="list-item" data-name="OPT_ID_187" data-para="true"><div data-html-name="para" data-name="OPT_ID_188" data-para="true">CK1 inhibition significantly blocks microenvironmental interactions of CLL cells.</div></li><li data-html-name="list-item" data-name="OPT_ID_189" data-para="true"><div data-html-name="para" data-name="OPT_ID_190" data-para="true">CK1 inhibition slows down development of CLL-like disease in the E<span data-html-name="unicode-char">μ</span>-TCL1 mouse model.</div></li></ul></div></div><div data-html-name="abstract" data-name="OPT_ID_191" data-para="true"><span data-auto-generated="true" data-html-name="section-title" aria-level="2">Abstract</span><div data-html-name="para" data-name="OPT_ID_192" data-para="true">Casein kinase 1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> (CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span>) is a key component of noncanonical Wnt signaling pathways, which were shown previously to drive pathogenesis of chronic lymphocytic leukemia (CLL). In this study, we investigated thoroughly the effects of CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibition on the primary CLL cells and analyzed the therapeutic potential in vivo using 2 murine model systems based on the E<span data-html-name="unicode-char">µ</span>-TCL1<span data-html-name="unicode-char">–</span>induced leukemia (syngeneic adoptive transfer model and spontaneous disease development), which resembles closely human CLL. We can demonstrate that the CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibitor PF-670462 significantly blocks microenvironmental interactions (chemotaxis, invasion, and communication with stromal cells in primary CLL cells in all major subtypes of CLL). In the mouse models, CK1 inhibition slows down accumulation of leukemic cells in the peripheral blood and spleen and prevents onset of anemia. As a consequence, PF-670462 treatment results in a significantly longer overall survival. Importantly, CK1 inhibition has synergistic effects to the B-cell receptor (BCR) inhibitors such as ibrutinib in vitro and significantly improves ibrutinib effects in vivo. Mice treated with a combination of PF-670462 and ibrutinib show the slowest progression of disease and survive significantly longer compared with ibrutinib-only treatment when the therapy is discontinued. In summary, this preclinical testing of CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibitor PF-670462 demonstrates that CK1 may serve as a novel therapeutic target in CLL, acting in synergy with BCR inhibitors. Our work provides evidence that targeting CK1 can represent an alternative or addition to the therapeutic strategies based on BCR signaling and antiapoptotic signaling (BCL-2) inhibition.</div></div><div data-html-name="graphical_abstract" data-name="OPT_ID_193" data-attr-abstract-type="graphical" data-para="true" data-id="ga"><h2 data-html-name="section-title" aria-level="2" data-name="OPT_ID_194" data-para="true">Visual Abstract</h2><div data-html-name="para" data-name="OPT_ID_195" data-para="true"><figure data-html-name="figure" data-name="OPT_ID_196" data-attr-id="absf1" data-attr-position="float" data-para="true"><div class="wrapper" data-name="OPT_ID_197" data-para="true"><div class="container-image"><img src="https://pgc-dev-test.s3.amazonaws.com/13398/" class="imgrsize" width="" height="" data-height="" data-width="" data-id="OPT_ID_197" data-web-src="https://pgc-dev-test.s3.amazonaws.com/13398/" /></div></div></figure></div></div><div id="funding-container"><span id="funding_title" data-auto-generated="true">Funding Information</span></div></div></section><section data-html-name="section" data-name="OPT_ID_201" data-attr-sec-type="intro" data-para="true"><h2 data-html-name="section-title" aria-level="2" data-name="OPT_ID_202" data-para="true">Introduction</h2><div data-html-name="para" data-name="OPT_ID_203" data-para="true">Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disorder defined by the accumulation of clonal B lymphocytes with typical immunophenotypic profile (CD5, CD19, CD23, ROR1 positive) in peripheral blood (PB), bone marrow (BM), and lymphoid organs.</div><div data-html-name="para" data-name="OPT_ID_204" data-para="true">It has been recognized that CLL is driven by multiple signaling pathways, primarily promoting interaction with protective microenvironment and subsequently survival and proliferation of the malignant cells.<span data-format="superscript" data-actor="org" data-name="OPT_ID_205"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_206"><span data-history="original" data-attr-rid="B1 B2 B3">1-3</span></cite></span> Signaling machineries mediating communication with microenvironment, mainly B-cell receptor (BCR) and chemokine-induced signaling pathways, have become the main focus of novel therapeutic strategies with BCR-associated kinase inhibitors, such as ibrutinib (Bruton tyrosine kinase [BTK] inhibitor) and idelalisib (phosphatidylinositol 3-kinase [PI3K] <span data-html-name="unicode-char">δ</span> inhibitor).</div><div data-html-name="para" data-name="OPT_ID_207" data-para="true">Recently, noncanonical Wnt/planar cell polarity (PCP) pathway, driven by ROR1 receptor,<span data-format="superscript" data-actor="org" data-name="OPT_ID_208"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_209"><span data-history="original" data-attr-rid="B4 B5 B6">4-6</span></cite></span> has been recognized as an additional mechanism required for the communication <span data-html-name="inline-formula" data-name="OPT_ID_210" data-para="true"><span data-html-name="math" data-current-version="1" data-standard-html-version="1.0" data-math-mode="editable" data-name="OPT_ID_211" data-math-type="inline"><span data-version="1"><span data-name="mathml"><math altimg="i1.gif" data-name="OPT_ID_211" data-attr-id="i1"><mrow optname="OPT_ID_212"><mi optname="OPT_ID_213">θ</mi><mo optname="OPT_ID_214">=</mo><mrow optname="OPT_ID_215"><mrow optname="OPT_ID_216"><msub optname="OPT_ID_217"><mi optname="OPT_ID_218">τ</mi><mi optname="OPT_ID_219">b</mi></msub></mrow><mo optname="OPT_ID_220">/</mo><mrow optname="OPT_ID_221"><mrow optname="OPT_ID_222"><mfenced open="(" close=")"><mrow><mrow optname="OPT_ID_224"><msub optname="OPT_ID_225"><mi optname="OPT_ID_226">ρ</mi><mi optname="OPT_ID_227">p</mi></msub><mo optname="OPT_ID_228">−</mo><msub optname="OPT_ID_229"><mi optname="OPT_ID_230">ρ</mi><mi optname="OPT_ID_231">f</mi></msub></mrow></mrow></mfenced></mrow><mi optname="OPT_ID_233">g</mi><mi optname="OPT_ID_234">d</mi></mrow></mrow></mrow></math></span></span></span></span> of CLL cells with their microenvironment involved in CLL pathogenesis. Wnt/PCP drives the pathogenesis of CLL primarily via regulation of chemotaxis and cell polarity,<span data-format="superscript" data-actor="org" data-name="OPT_ID_235"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_236"><span data-history="original" data-attr-rid="B7 B8 B9 B10 B11">7-11</span></cite></span> but reports demonstrating effects on survival and proliferation also exist.<span data-format="superscript" data-actor="org" data-name="OPT_ID_237"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_238"><span data-history="original" data-attr-rid="B11">11</span></cite></span> These clinical observations were functionally supported by genetic analysis of the E<span data-html-name="unicode-char">µ</span>-TCL1 transgenic mouse model of CLL where overexpression of Wnt/PCP receptor, ROR1, enhanced leukemogenesis,<span data-format="superscript" data-actor="org" data-name="OPT_ID_239"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_240"><span data-history="original" data-attr-rid="B12">12</span></cite></span> whereas elimination of FRIZZLED 6, another component of the Wnt/PCP receptor complex, delayed CLL development.<span data-format="superscript" data-actor="org" data-name="OPT_ID_241"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_242"><span data-history="original" data-attr-rid="B13">13</span></cite></span> Importantly, although best studied in CLL, the Wnt/PCP pathway can have similar importance also in other lymphoid malignancies.<span data-format="superscript" data-actor="org" data-name="OPT_ID_243"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_244"><span data-history="original" data-attr-rid="B14 B15 B16 B17">14-17</span></cite></span></div><div data-html-name="para" data-name="OPT_ID_245" data-para="true">Based on these facts, we hypothesized that the Wnt/PCP pathway can represent a potential therapeutic target in CLL. We have shown previously that casein kinase 1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> (CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span>) activity is indispensable for Wnt/PCP signaling in the context of CLL<span data-format="superscript" data-actor="org" data-name="OPT_ID_246"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_247"><span data-history="original" data-attr-rid="B7 B8 B18">7,8,18</span></cite></span> and as such may serve as a druggable component in the Wnt/PCP pathway relevant for CLL. In this study, we aimed to investigate the effects of CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibition on the behavior of primary CLL cells with a focus on the CLL-microenvironment communication and on the leukemia development and progression in vivo using 2 murine model systems based on E<span data-html-name="unicode-char">µ</span>-TCL1<span data-html-name="unicode-char">–</span>induced leukemia. Our work provides evidence that targeting CK1 is an alternative to the therapeutic strategies based on BCR and antiapoptotic signaling (BCL-2) inhibition.</div></section><section data-html-name="section" data-name="OPT_ID_248" data-attr-sec-type="methods" data-para="true"><h2 data-html-name="section-title" aria-level="2" data-name="OPT_ID_249" data-para="true">Methods</h2><section data-html-name="section" data-name="OPT_ID_250" data-para="true"><h3 data-html-name="section-title" aria-level="3" data-name="OPT_ID_251" data-para="true">Primary CLL samples, healthy controls, and cell lines</h3><div data-html-name="para" data-name="OPT_ID_252" data-para="true">Primary cells were isolated from PB of CLL patients monitored and treated at the Department of Internal Medicine<span data-html-name="unicode-char">–</span>Hematology and Oncology, University Hospital Brno, according to international criteria.<span data-format="superscript" data-actor="org" data-name="OPT_ID_253"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_254"><span data-history="original" data-attr-rid="B19">19</span></cite></span> All samples including age-matched nonmalignant controls were taken after written informed consent in accordance with the Declaration of Helsinki under protocols approved by the Ethical Committee of the University Hospital Brno. Cells were separated using non<span data-html-name="unicode-char">–</span>B-cell depletion techniques (RosetteSep kits, StemCell).<span data-format="superscript" data-actor="org" data-name="OPT_ID_255"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_256"><span data-history="original" data-attr-rid="B7">7</span></cite></span> The separation efficiency was assessed by flow cytometry, and all tested samples contained <span data-html-name="unicode-char">≥</span>98% B cells in the case of CLL cells and 70% to 80% in the case of nonmalignant controls. Basic clinical characteristics of the patients are summarized in supplemental Table 1 (see the <span data-format="italic" data-actor="org" data-name="OPT_ID_257">Blood</span> Web site). MEC-1<span data-format="superscript" data-actor="org" data-name="OPT_ID_258"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_259"><span data-history="original" data-attr-rid="B20">20</span></cite></span> cells (DSMZ) and HEK293T and M210B4<span data-format="superscript" data-actor="org" data-name="OPT_ID_260"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_261"><span data-history="original" data-attr-rid="B21">21</span></cite></span> cells (both ATCC) were used as model cell lines. Cell culture conditions are described in the supplemental Data.</div></section><section data-html-name="section" data-name="OPT_ID_262" data-para="true"><h3 data-html-name="section-title" aria-level="3" data-name="OPT_ID_263" data-para="true">Cell treatments</h3><div data-html-name="para" data-name="OPT_ID_264" data-para="true">The following <span data-html-name="inline-formula" data-name="OPT_ID_265" data-para="true"><span data-html-name="math" data-current-version="1" data-standard-html-version="1.0" data-math-mode="editable" data-name="OPT_ID_266" data-math-type="inline"><span data-version="1"><span data-name="mathml"><math altimg="i2.gif" data-name="OPT_ID_266" data-attr-id="i2"><mrow optname="OPT_ID_267"><mi optname="OPT_ID_268">J</mi><mo optname="OPT_ID_269">≈</mo><msup optname="OPT_ID_270"><mrow optname="OPT_ID_271"><mrow optname="OPT_ID_272"><mfenced open="(" close=")"><mrow><mrow optname="OPT_ID_274"><mi optname="OPT_ID_275">θ</mi><mo optname="OPT_ID_276">−</mo><msup optname="OPT_ID_277"><mi optname="OPT_ID_278">θ</mi><mi optname="OPT_ID_279">c</mi></msup></mrow></mrow></mfenced></mrow></mrow><mi optname="OPT_ID_281">β</mi></msup></mrow></math></span></span></span></span> chemicals were used for in vitro experiments: 10 to 150 <span data-html-name="unicode-char">µ</span>M PF-4800567 (RnD Systems), 0.03 to 50 <span data-html-name="unicode-char">µ</span>M PF-670462 (Tocris, DC Chemicals), 5 to 125 <span data-html-name="unicode-char">µ</span>M D4476 (Calbiochem), and 0.03 to 3 <span data-html-name="unicode-char">µ</span>M ibrutinib (PCI-32765, DC Chemicals). Control conditions contained the corresponding amount of dimethyl sulfoxide (Sigma Aldrich). Viability of cells was assessed in parallel by staining (tetramethylrhodamine, 2 <span data-html-name="unicode-char">μ</span>M, 15 minutes at room temperature; Invitrogen) or by cell morphology, based on flow cytometric analysis (FSC/SSC).</div></section><section data-html-name="section" data-name="OPT_ID_282" data-para="true"><h3 data-html-name="section-title" aria-level="3" data-name="OPT_ID_283" data-para="true">Functional in vitro experiments</h3><div data-html-name="para" data-name="OPT_ID_284" data-para="true">Detailed protocols of the transwell migration assay, double-species coculture system and analysis of CCL3/4 levels produced by CLL cells (gene expression and protein secretion), CK1<span data-html-name="unicode-char">ε</span> autophosphorylation assay for assessment of CK1<span data-html-name="unicode-char">ε</span> activity, BCR pathway-stimulation, and subsequent western blotting analysis are all described in detail in the supplemental Data.</div></section><section data-html-name="section" data-name="OPT_ID_285" data-para="true"><h3 data-html-name="section-title" aria-level="3" data-name="OPT_ID_286" data-para="true">Animals</h3><div data-html-name="para" data-name="OPT_ID_287" data-para="true">All animal experiments were performed with approval of the Ethics Committee in accordance with the international ARRIVE guidelines.<span data-format="superscript" data-actor="org" data-name="OPT_ID_288"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_289"><span data-history="original" data-attr-rid="B22">22</span></cite></span> The E<span data-html-name="unicode-char">µ</span>-TCL1<span data-format="superscript" data-actor="org" data-name="OPT_ID_290"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_291"><span data-history="original" data-attr-rid="B23">23</span></cite></span> mouse model system is described in detail in the supplemental Data. Disease progression was monitored by regular PB sampling followed by flow cytometric analysis as described previously<span data-format="superscript" data-actor="org" data-name="OPT_ID_292"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_293"><span data-history="original" data-attr-rid="B12">12</span></cite></span> and in the supplemental Data, which enabled quantification of white blood cells (WBCs) as well as distinct lymphocyte populations: leukemic B cells (CD5<span data-format="superscript" data-actor="org" data-name="OPT_ID_294">low</span>CD45R<span data-format="superscript" data-actor="org" data-name="OPT_ID_295">low</span>), normal B cells (CD5<span data-format="superscript" data-actor="org" data-name="OPT_ID_296">neg</span>CD45R<span data-format="superscript" data-actor="org" data-name="OPT_ID_297">high</span>), and T cells (CD5<span data-format="superscript" data-actor="org" data-name="OPT_ID_298">high</span>CD45R<span data-format="superscript" data-actor="org" data-name="OPT_ID_299">neg</span>). Analysis was performed on a BD Accuri C6 (BD Biosciences) flow cytometer, and data were analyzed by BD Accuri C6 Software. Hematological analysis of PB was performed by hemoanalyzer Mindray BC-5300VET (Mindray). Spleen volume was monitored by high-frequency ultrasound VEVO 2100 System (FUJIFILM Visual Sonic; measured at 30 MHz) and analyzed by the VEVO 2100 software. For this application, animals were anesthetized by isofurane gas.</div></section><section data-html-name="section" data-name="OPT_ID_300" data-para="true"><h3 data-html-name="section-title" aria-level="3" data-name="OPT_ID_301" data-para="true">Statistics</h3><div data-html-name="para" data-name="OPT_ID_302" data-para="true">All statistical tests were performed as 2-sided using GraphPad Prism 5 (GraphPad Software Inc.; described in detail in the supplemental Data). Asterisks were used in graphs to visualize <span data-format="italic" data-actor="org" data-name="OPT_ID_303">P</span> values: *<span data-format="italic" data-actor="org" data-name="OPT_ID_304">P</span> <span data-html-name="unicode-char">≤</span> .05, **<span data-format="italic" data-actor="org" data-name="OPT_ID_305">P</span> <span data-html-name="unicode-char">≤</span> .01, ***<span data-format="italic" data-actor="org" data-name="OPT_ID_306">P</span> <span data-html-name="unicode-char">≤</span> .001, ****<span data-format="italic" data-actor="org" data-name="OPT_ID_307">P</span> <span data-html-name="unicode-char">≤</span> .0001; n.s. indicates <span data-html-name="unicode-char">“</span>not significant.<span data-html-name="unicode-char">”</span> The standard level of statistical significance was <span data-format="italic" data-actor="org" data-name="OPT_ID_308">P</span> <span data-html-name="unicode-char">≤</span> .05.</div></section></section><section data-html-name="section" data-name="OPT_ID_309" data-attr-sec-type="results" data-para="true"><h2 data-html-name="section-title" aria-level="2" data-name="OPT_ID_310" data-para="true">Results</h2><section data-html-name="section" data-name="OPT_ID_311" data-para="true"><h3 data-html-name="section-title" aria-level="3" data-name="OPT_ID_312" data-para="true">CK1<span data-html-name="unicode-char">ε</span> is upregulated in CLL, and inhibition of CK1<span data-html-name="unicode-char">ε</span> blocks CLL chemotaxis</h3><div data-html-name="para" data-name="OPT_ID_313" data-para="true">To support the hypothesis that CK1<span data-html-name="unicode-char">ε</span> is not only a key molecule of the Wnt/PCP pathway, but also a suitable target for CLL therapy, we have analyzed the expression profile of <span data-format="italic" data-actor="org" data-name="OPT_ID_314">CSNK1E</span>, encoding for CK1<span data-html-name="unicode-char">ε</span>, using microarray data publicly available in the Oncomine database.<span data-format="superscript" data-actor="org" data-name="OPT_ID_315"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_316"><span data-history="original" data-attr-rid="B24">24</span></cite></span> The 2 independent data sets<span data-format="superscript" data-actor="org" data-name="OPT_ID_317"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_318"><span data-history="original" data-attr-rid="B25 B26">25,26</span></cite></span> provide evidence that <span data-format="italic" data-actor="org" data-name="OPT_ID_319">CSNK1E</span> is overexpressed in CLL cells compared with nonmalignant B-cell populations in PB (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_320"><span data-history="original" data-attr-rid="F1">Figure 1A</span></cite>) and BM (supplemental Figure 1A). Interestingly, the expression levels were comparably low between na<span data-html-name="unicode-char">ï</span>ve and memory PB B cells isolated from healthy donors (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_321"><span data-history="original" data-attr-rid="F1">Figure 1A</span></cite>). This upregulation translates into increased protein levels of CK1<span data-html-name="unicode-char">ε</span> in CLL cells compared with nonmalignant B cells (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_322"><span data-history="original" data-attr-rid="F1">Figure 1Bi-ii</span></cite>). This confirms our earlier findings<span data-format="superscript" data-actor="org" data-name="OPT_ID_323"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_324"><span data-history="original" data-attr-rid="B7">7</span></cite></span> and suggests that CK1<span data-html-name="unicode-char">ε</span> can be a druggable target with different expression in CLL and healthy B cells, similarly to the ROR1 receptor.<span data-format="superscript" data-actor="org" data-name="OPT_ID_325"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_326"><span data-history="original" data-attr-rid="B4 B5 B6">4-6</span></cite></span></div><figure data-html-name="figure" data-name="OPT_ID_327" data-attr-id="F1" data-para="true"><div class="wrapper" data-name="OPT_ID_341" data-para="true"><div class="container-image"><img src="https://pgc-dev-test.s3.amazonaws.com/13398/" class="imgrsize" width="" height="" data-height="" data-width="" data-id="OPT_ID_341" data-web-src="https://pgc-dev-test.s3.amazonaws.com/13398/" /></div></div><span data-html-name="label" data-name="OPT_ID_328" data-para="true">Figure 1.</span><span data-auto-generated="true"><span data-html-name="unicode-char"> </span></span><figcaption data-html-name="caption" data-name="OPT_ID_329" data-para="true"><div data-html-name="para" data-name="OPT_ID_330" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_331">CK1<span data-html-name="unicode-char">ε</span> is upregulated in CLL, and its activity is inhibited by PF-670462 inhibitor at low micromolar concentration.</span> (A) <span data-format="italic" data-actor="org" data-name="OPT_ID_332">CSNK1E</span> expression (probe 38019_at); microarray data obtained from the Oncomine database<span data-format="superscript" data-actor="org" data-name="OPT_ID_333"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_334"><span data-history="original" data-attr-rid="B24">24</span></cite></span> (<span data-html-name="unicode-char">‘</span>Basso Lymphoma<span data-html-name="unicode-char">’</span> data set<span data-format="superscript" data-actor="org" data-name="OPT_ID_335"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_336"><span data-history="original" data-attr-rid="B25">25</span></cite></span>). CLL PB samples (N = 34) compared with nonmalignant PB B-cell populations: na<span data-html-name="unicode-char">ï</span>ve (N = 5) and memory (N = 5) (1-way analysis of variance [ANOVA], <span data-format="italic" data-actor="org" data-name="OPT_ID_337">P</span> &lt; .0001). Gray lines represent median. (B) Protein levels in primary CLL samples (N = 6) and healthy controls (buffy coats, N = 3) were analyzed by western blotting (i). Quantification of detected CK1<span data-html-name="unicode-char">ε</span> levels performed by ImageJ software (<span data-format="italic" data-actor="org" data-name="OPT_ID_338">P</span> = .0310, unpaired Student <span data-format="italic" data-actor="org" data-name="OPT_ID_339">t</span> test) (ii). CK1<span data-html-name="unicode-char">ε</span> protein level in MEC-1 cell line in comparison with primary CLL and healthy control samples (iii). Activity of CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibitor PF-670462 was tested in a transwell migration assay (6 hours, CCL19-induced chemotaxis) using MEC-1 cell line (C; N = 3) and 4 freshly isolated primary CLL samples (D). Relative migration index (left y-axis, black) represents ratio between cells migrated toward chemokine in the inhibitor-treated and control conditions. Viability (right y-axis, gray) was tested in parallel by tetramethylrhodamine staining. Vertical dashed lines represent EC<span data-format="subscript" data-actor="org" data-name="OPT_ID_340">50</span> values. Symbols represent mean <span data-html-name="unicode-char">±</span> standard error of the mean (SEM). (E) Activity of CK1<span data-html-name="unicode-char">ε</span> after PF-670462/dimethyl sulfoxide treatment (2 hours) in primary CLL cells stimulated by 50 nM Calyculin A (1 hour); upper band represents autophosphorylated form (PS-CK1<span data-html-name="unicode-char">ε</span>), which is not present in an unstimulated sample and is lost dose-dependently upon CK1<span data-html-name="unicode-char">ε</span> inhibition with maximum effect at 10 <span data-html-name="unicode-char">µ</span>M concentration. Representative result is presented (N = 3).</div></figcaption></figure><div data-html-name="para" data-name="OPT_ID_342" data-para="true">As the next step, we have assayed 3 commercially available compounds reported to inhibit CK1<span data-html-name="unicode-char">δ</span> and/or CK1<span data-html-name="unicode-char">ε</span>. The tested compounds (PF-4800567, PF-670462, and D4476) were selected because of their low 50% inhibitory concentration (IC<span data-format="subscript" data-actor="org" data-name="OPT_ID_343">50</span>) values and well-characterized specificity. All compounds are adenosine triphosphate<span data-html-name="unicode-char">–</span>competing CK1 inhibitors. PF-4800567 displays 22-fold greater potency toward CK1<span data-html-name="unicode-char">ε</span> than CK1<span data-html-name="unicode-char">δ</span> (IC<span data-format="subscript" data-actor="org" data-name="OPT_ID_344">50</span> values of 32 nM for CK1<span data-html-name="unicode-char">ε</span> and 711 nM for CK1<span data-html-name="unicode-char">δ</span>),<span data-format="superscript" data-actor="org" data-name="OPT_ID_345"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_346"><span data-history="original" data-attr-rid="B27">27</span></cite></span> the PF-670462 compound is a potent and selective inhibitor of both isoforms (IC<span data-format="subscript" data-actor="org" data-name="OPT_ID_347">50</span> values of 7.7 nM for CK1<span data-html-name="unicode-char">ε</span> and 14 nM for CK1<span data-html-name="unicode-char">δ</span>),<span data-format="superscript" data-actor="org" data-name="OPT_ID_348"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_349"><span data-history="original" data-attr-rid="B28">28</span></cite></span> whereas D4476 is a less specific CK1<span data-html-name="unicode-char">δ</span> and ALK5 inhibitor (IC<span data-format="subscript" data-actor="org" data-name="OPT_ID_350">50</span> values of 0.2 <span data-html-name="unicode-char">μ</span>M and 0.5 <span data-html-name="unicode-char">μ</span>M, respectively).<span data-format="superscript" data-actor="org" data-name="OPT_ID_351"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_352"><span data-history="original" data-attr-rid="B29">29</span></cite></span></div><div data-html-name="para" data-name="OPT_ID_353" data-para="true">Using the well-established transwell migration assay,<span data-format="superscript" data-actor="org" data-name="OPT_ID_354"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_355"><span data-history="original" data-attr-rid="B7">7</span></cite></span> we have quantified effects of the inhibitors on chemotaxis of the MEC-1 cell line, originating from CLL prolymphocytic transformation,<span data-format="superscript" data-actor="org" data-name="OPT_ID_356"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_357"><span data-history="original" data-attr-rid="B20">20</span></cite></span> which was shown to express high levels of CK1<span data-html-name="unicode-char">ε</span> and other Wnt/PCP pathway components<span data-format="superscript" data-actor="org" data-name="OPT_ID_358"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_359"><span data-history="original" data-attr-rid="B7">7</span></cite></span> (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_360"><span data-history="original" data-attr-rid="F1">Figure 1Biii</span></cite>) with the exception of the ROR1 receptor.<span data-format="superscript" data-actor="org" data-name="OPT_ID_361"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_362"><span data-history="original" data-attr-rid="B11">11</span></cite></span> All inhibitors reduced significantly MEC-1 chemotaxis toward CCL19 chemokine (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_363"><span data-history="original" data-attr-rid="F1">Figure 1C</span></cite>; supplemental Figure 1Bi-ii, left y-axis, in black) but did not affect cell viability during the 6-hour migration protocol (right t-axis, in gray). PF-670462 inhibitor was the most potent (50% effective concentration [EC<span data-format="subscript" data-actor="org" data-name="OPT_ID_364">50</span>] = 2.4 <span data-html-name="unicode-char">μ</span>M) with &gt;20 times lower EC<span data-format="subscript" data-actor="org" data-name="OPT_ID_365">50</span> than the other inhibitors (PF-4800567, EC<span data-format="subscript" data-actor="org" data-name="OPT_ID_366">50</span> = 72.1 <span data-html-name="unicode-char">μ</span>M; D4476, EC<span data-format="subscript" data-actor="org" data-name="OPT_ID_367">50</span> = 88.0 <span data-html-name="unicode-char">μ</span>M) and as such was used in further experiments. Findings from the MEC-1 model were confirmed for primary CLL cells; in the same experimental settings, the EC<span data-format="subscript" data-actor="org" data-name="OPT_ID_368">50</span> value was determined as 2.8 <span data-html-name="unicode-char">μ</span>M in the case of freshly isolated CLL cells (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_369"><span data-history="original" data-attr-rid="F1">Figure 1D</span></cite>) and 0.18 <span data-html-name="unicode-char">μ</span>M for primary CLL cells that went through a freeze-thaw cycle (supplemental Figure 1Biii). Certain variability was observed among individual CLL patients (see supplemental Figure 1C-D), with EC<span data-format="subscript" data-actor="org" data-name="OPT_ID_370">50</span> ranging from 1.8 to 6.2 <span data-html-name="unicode-char">μ</span>M. To confirm efficient inhibition of CK1<span data-html-name="unicode-char">ε</span> activity in the in-cell assays, we have performed CK1 autophosphorylation assay in 3 primary CLL samples (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_371"><span data-history="original" data-attr-rid="F1">Figure 1E</span></cite>). Results <cite data-standard-html-version="1.0" data-html-name="eqn" data-attr-ref-type="disp-formula" data-name="OPT_ID_372"><span data-history="original" data-attr-rid="eq1">Eq. <span data-format="bold" data-actor="org" data-name="OPT_ID_373">1</span></span></cite> showed that the kinase is almost completely inhibited at 10 <span data-html-name="unicode-char">μ</span>M concentration; therefore, this dose was selected for further testing, and experiments were performed exclusively with fresh primary samples with the exception of the experiment presented in <cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_374"><span data-history="original" data-attr-rid="F6">Figure 6G</span></cite> and related supplemental Data.<span data-html-name="display-formula" data-name="OPT_ID_375" data-attr-id="eq1" data-para="true"><span data-html-name="math" data-current-version="1" data-standard-html-version="1.0" data-math-mode="editable" data-name="OPT_ID_376" data-math-type="display-numbered"><span data-version="1"><span data-name="mathml"><math altimg="me1.gif" data-name="OPT_ID_376" data-attr-display="block" data-attr-id="me1"><mrow optname="OPT_ID_377"><mi optname="OPT_ID_378">σ</mi><mrow optname="OPT_ID_379"><mfenced open="(" close=")"><mrow><mrow optname="OPT_ID_381"><mi optname="OPT_ID_382">i</mi><mo optname="OPT_ID_383">,</mo><mi optname="OPT_ID_384">j</mi></mrow></mrow></mfenced></mrow><mo optname="OPT_ID_386">=</mo><mfrac optname="OPT_ID_387"><mn optname="OPT_ID_388">1</mn><mi optname="OPT_ID_389">N</mi></mfrac><mstyle displaystyle="true" optname="OPT_ID_390"><munder optname="OPT_ID_391"><mo optname="OPT_ID_392">∑</mo><mrow optname="OPT_ID_393"><mtext optname="OPT_ID_394">particles</mtext></mrow></munder><mrow optname="OPT_ID_395"><mrow optname="OPT_ID_396"><mfenced open="(" close=")"><mrow><mrow optname="OPT_ID_398"><mrow optname="OPT_ID_399"><mi optname="OPT_ID_400">u</mi><mo optname="OPT_ID_401">/</mo><mi optname="OPT_ID_402">U</mi></mrow></mrow></mrow></mfenced></mrow></mrow></mstyle><mo optname="OPT_ID_404">,</mo></mrow></math></span></span></span><span data-html-name="math-label" data-name="OPT_ID_405" data-para="true">[1]</span></span></div><figure data-html-name="figure" data-name="OPT_ID_406" data-attr-id="F6" data-para="true"><div class="wrapper" data-name="OPT_ID_452" data-para="true"><div class="container-image"><img src="https://pgc-dev-test.s3.amazonaws.com/13398/" class="imgrsize" width="" height="" data-height="" data-width="" data-id="OPT_ID_452" data-web-src="https://pgc-dev-test.s3.amazonaws.com/13398/" /></div></div><span data-html-name="label" data-name="OPT_ID_407" data-para="true">Figure 6.</span><span data-auto-generated="true"><span data-html-name="unicode-char"> </span></span><figcaption data-html-name="caption" data-name="OPT_ID_408" data-para="true"><div data-html-name="para" data-name="OPT_ID_409" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_410">Combinatory effects of CK1 inhibition by PF-670462 and ibrutinib.</span> (A) Scheme of the inhibitors<span data-html-name="unicode-char">’</span> mode of action. Common processes in CLL cells can be targeted by inhibition of either BCR or CK1-dependent signaling. (B) Inhibitory effects of PF-670462 and ibrutinib on CK1<span data-html-name="unicode-char">ε</span> activity in primary CLL cells were tested via CK1 autophosphorylation assay. Representative western blotting analysis is presented. PF-670462 inhibits almost completely CK1<span data-html-name="unicode-char">ε</span> activity at a 10-<span data-html-name="unicode-char">µ</span>M dose. (C) Inhibitory effects of PF-670462 and ibrutinib on BCR pathway activity (triggered by anti<span data-html-name="unicode-char">–</span>immunoglobulin M [IgM], 4 minutes). Representative western blotting analysis is presented. Ibrutinib almost completely blocks activity of BTK in primary CLL cells already at 0.1-<span data-html-name="unicode-char">µ</span>M dose (determined by autophosphorylation of BTK at Y223 and phosphorylation of its substrate PLC<span data-html-name="unicode-char">γ</span>2 at Y1217) and at higher concentrations also affects activity of the other pathway components, such as SYK (phosphorylation of Y525/526) <cite data-standard-html-version="1.0" data-html-name="eqn" data-attr-ref-type="disp-formula" data-name="OPT_ID_411"><span data-history="original" data-attr-rid="eq2">Eq. <span data-format="bold" data-actor="org" data-name="OPT_ID_412">2</span></span></cite> or ERK1/2 (extracellular signal-regulated kinase 1/2). (D-E) Quantification of the western blotting analysis performed in panels B and C; further quantification is presented in supplemental Figure 6A-C. Columns represent mean <span data-html-name="unicode-char">±</span> standard deviation (SD). (F) Combination of ibrutinib and CK1 inhibitor treatment leads to significantly stronger inhibition of cell chemotaxis toward both CXCL12 (N = 5, <span data-format="italic" data-actor="org" data-name="OPT_ID_413">P</span> = .0156; ratio-paired Student <span data-format="italic" data-actor="org" data-name="OPT_ID_414">t</span> test) and CCL19 (N = 11,<span data-html-name="display-formula" data-name="OPT_ID_415" data-attr-id="eq2" data-para="true"><span data-html-name="math" data-current-version="1" data-standard-html-version="1.0" data-math-mode="editable" data-name="OPT_ID_416" data-math-type="display-numbered"><span data-version="1"><span data-name="mathml"><math altimg="me2.gif" data-name="OPT_ID_416" data-attr-display="block" data-attr-id="me2"><mrow optname="OPT_ID_417"><mi optname="OPT_ID_418">J</mi><mo optname="OPT_ID_419">=</mo><mfrac optname="OPT_ID_420"><mn optname="OPT_ID_421">1</mn><mrow optname="OPT_ID_422"><msub optname="OPT_ID_423"><mi optname="OPT_ID_424">N</mi><mrow optname="OPT_ID_425"><mtext optname="OPT_ID_426">pixels</mtext></mrow></msub></mrow></mfrac><mstyle displaystyle="true" optname="OPT_ID_427"><munder optname="OPT_ID_428"><mo optname="OPT_ID_429">∑</mo><mrow optname="OPT_ID_430"><mi optname="OPT_ID_431">i</mi><mo optname="OPT_ID_432">,</mo><mi optname="OPT_ID_433">j</mi></mrow></munder><mrow optname="OPT_ID_434"><mi optname="OPT_ID_435">σ</mi><mrow optname="OPT_ID_436"><mfenced open="(" close=")"><mrow><mrow optname="OPT_ID_438"><mi optname="OPT_ID_439">i</mi><mo optname="OPT_ID_440">,</mo><mi optname="OPT_ID_441">j</mi></mrow></mrow></mfenced></mrow></mrow></mstyle><mo optname="OPT_ID_443">.</mo></mrow></math></span></span></span><span data-html-name="math-label" data-name="OPT_ID_444" data-para="true">[2]</span></span> <span data-format="italic" data-actor="org" data-name="OPT_ID_445">P</span> = .0010; Wilcoxon matched-pairs signed rank test). Data were normalized toward the condition treated by both ibrutinib and CK1 inhibitor. Asterisks represent results of the paired-tests of raw MIs from supplemental Figure 6D-E. Columns represent mean <span data-html-name="unicode-char">±</span> SEM. (G) Combination of ibrutinib and CK1 inhibitor treatments showed synergistic effects on chemotaxis of primary CLL cells toward CCL19 chemokine in a transwell assay (N = 3). Inhibitory effects are presented as a fold change of control, concentration range of 0.03 to 1 <span data-html-name="unicode-char">µ</span>M was tested in the case of ibrutinib and 0.03 to 10 <span data-html-name="unicode-char">µ</span>M in the case of CK1 inhibitor. Mean <span data-html-name="unicode-char">±</span> SD is presented. Corresponding isobolographic analysis with detailed description is presented in supplemental Figure 6I; data for 3 individual CLL patients are presented in supplemental Figure 6Ji-iii. (H) AT experiment was performed as described in <cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_446"><span data-history="original" data-attr-rid="F4">Figure 4</span></cite>. Inhibitor treatment lasted until day 42, when control animals reached highly progressed stage of the disease, while still no leukemia was detected in the animals treated by CK1 inhibitor/ibrutinib combination. Significant difference between ibrutinib only and ibrutinib/CK1 inhibitor combination treatment was detected (ANOVA, Tukey<span data-html-name="unicode-char">’</span>s multiple comparisons test), and both single treatments were significantly different from control (N = 8 animals/group, 6 in the control group). Dashed vertical line marks the day of spleen size analysis by ultrasound. Mean <span data-html-name="unicode-char">±</span> SD is presented. (I) Spleen volume as determined by ultrasound at day 38 (N = 4/4/4/6/4). Gray lines represent median; dashed line highlights WT spleen size. All treatments were significantly different from the control group (1-way ANOVA, <span data-format="italic" data-actor="org" data-name="OPT_ID_447">P</span> &lt; .0001). (J) Follow-up and overall survival after the end of treatments at day 42. Ibrutinib-treated animals show shorter overall survival (median 74.5 days) compared with the animals treated by both inhibitors (89 days, <span data-format="italic" data-actor="org" data-name="OPT_ID_448">P</span> = .001) or CK1 inhibitor alone (median not defined, <span data-format="italic" data-actor="org" data-name="OPT_ID_449">P</span> &lt; .0001) and control group (85 days, <span data-format="italic" data-actor="org" data-name="OPT_ID_450">P</span> = .0083). Results of survival analysis are also significant for single CK1 inhibitor treatment vs control group (<span data-format="italic" data-actor="org" data-name="OPT_ID_451">P</span> = .0001, all log-rank test).</div></figcaption></figure></section><section data-html-name="section" data-name="OPT_ID_453" data-para="true"><h3 data-html-name="section-title" aria-level="3" data-name="OPT_ID_454" data-para="true">CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibitor PF-670462 efficiently blocks interactions with the microenvironment in all major subgroups of CLL patients</h3><div data-html-name="para" data-name="OPT_ID_455" data-para="true">In order to analyze the ability of CK1 inhibitor PF-670462 to block various means of the interaction of CLL cells with microenvironmental components, we have performed the following set of experiments <span data-html-name="inline-formula" data-name="OPT_ID_456" data-para="true"><span data-html-name="math" data-current-version="1" data-standard-html-version="1.0" data-math-mode="editable" data-name="OPT_ID_457" data-math-type="inline"><span data-version="1"><span data-name="mathml"><math altimg="i3.gif" data-name="OPT_ID_457" data-attr-id="i3"><mrow optname="OPT_ID_458"><mi optname="OPT_ID_459">P</mi><mrow optname="OPT_ID_460"><mfenced open="(" close=")"><mrow><mi optname="OPT_ID_462">σ</mi></mrow></mfenced></mrow></mrow></math></span></span></span></span> using primary CLL cells: chemotaxis toward chemokines (1) CXCL12 and (2) CCL19 involved in the process of B-cell/CLL cell homing to lymphoid organs and BM; (3) chemotaxis toward BM stromal cells, which provide complex and less defined mixture of stimulatory factors; and (4) integrin-mediated cell adhesion boosted by fibronectin, a component of extracellular matrix (ECM), which increases migration of CLL cells<span data-format="superscript" data-actor="org" data-name="OPT_ID_464"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_465"><span data-history="original" data-attr-rid="B30">30</span></cite></span> (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_466"><span data-history="original" data-attr-rid="F2">Figure 2A</span></cite>). The effects of CK1 inhibitor were analyzed using transwell assays. All microenvironmental stimuli were able to promote chemotaxis of primary CLL cells, albeit to a different extent. Importantly, we demonstrated that CK1 inhibition significantly decreased migration index in all tested conditions (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_467"><span data-history="original" data-attr-rid="F2">Figure 2B-E</span></cite>). These data provide evidence that the CK1 inhibition is a highly effective approach to block CLL cell chemotaxis.</div><figure data-html-name="figure" data-name="OPT_ID_468" data-attr-id="F2" data-para="true"><div class="wrapper" data-name="OPT_ID_476" data-para="true"><div class="container-image"><img src="https://pgc-dev-test.s3.amazonaws.com/13398/" class="imgrsize" width="" height="" data-height="" data-width="" data-id="OPT_ID_476" data-web-src="https://pgc-dev-test.s3.amazonaws.com/13398/" /></div></div><span data-html-name="label" data-name="OPT_ID_469" data-para="true">Figure 2.</span><span data-auto-generated="true"><span data-html-name="unicode-char"> </span></span><figcaption data-html-name="caption" data-name="OPT_ID_470" data-para="true"><div data-html-name="para" data-name="OPT_ID_471" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_472">CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibitor PF-670462 specifically blocks interaction of primary CLL cells with microenvironmental stimuli in vitro.</span> (A) Scheme of the applied treatments and analyzed CLL-microenvironment interactions. (B-E) Migration of primary CLL cells (N = 10-27) in presence or absence of PF-670462 was assayed using transwell assays. Cells were stimulated by 200 ng/mL CXCL12 (B) or CCL19 (C), BM stromal cells M210B4 (D), or ECM component fibronectin (E) stimulation. CK1 inhibitor treatment significantly blocked response to chemokines (<span data-format="italic" data-actor="org" data-name="OPT_ID_473">P</span> &lt; .0001 both for CXCL12 and CCL19, N = 27), BM stroma (<span data-format="italic" data-actor="org" data-name="OPT_ID_474">P</span> &lt; .0001, N = 15), and ECM (<span data-format="italic" data-actor="org" data-name="OPT_ID_475">P</span> = .0020, N = 10). MI, migration index.</div></figcaption></figure><div data-html-name="para" data-name="OPT_ID_477" data-para="true">CLL patients can be categorized into multiple subgroups, differing in their clinical and molecular characteristics. In order to assess differences in response to CK1 inhibition among individual CLL subtypes, we have stratified the patients analyzed in <cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_478"><span data-history="original" data-attr-rid="F2">Figure 2B-E</span></cite> using prognostic parameters such as IGHV status, Rai stage, hierarchical cytogenetics, or the therapy status at the time of sampling (for complete overview of the cases entering this analysis, see supplemental Table 1). Results of this analysis are summed up in <cite data-standard-html-version="1.0" data-html-name="table" data-attr-ref-type="table" data-name="OPT_ID_479"><span data-history="original" data-attr-rid="T1">Table 1</span></cite> (raw migration data are shown in supplemental Figure 2A-D; data are presented as percent of control in supplemental Figure 2E-H). Overall, the migration was significantly reduced by CK1 inhibition in all patient subgroups with enough data for statistical analysis.</div><div data-html-name="table-group" data-standard-html-version="1.0" data-name="OPT_ID_480" data-attr-id="T1" data-attr-position="float" data-para="true"><div data-html-name="table-label" data-name="OPT_ID_481" data-para="true">Table 1.</div><table data-name="OPT_ID_485" data-attr-frame="hsides" data-para="true"><caption data-name="OPT_ID_482" data-para="true"><div data-html-name="para" data-name="OPT_ID_483" data-para="true">CLL patient samples analyzed in <cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_484"><span data-history="original" data-attr-rid="F2">Figure 2B-E</span></cite></div></caption><thead data-name="OPT_ID_486" data-attr-valign="bottom" data-para="true"><tr data-name="OPT_ID_487" data-para="true"><th data-name="OPT_ID_488" rowspan="2" data-para="true"></th><th data-name="OPT_ID_489" colspan="2" data-align="center" data-para="true">IGHV</th><th data-name="OPT_ID_490" colspan="3" data-align="center" data-para="true">Rai at sampling</th><th data-name="OPT_ID_491" colspan="4" data-align="center" data-para="true">Hierarchical cytogenetics</th><th data-name="OPT_ID_492" colspan="2" data-align="center" data-para="true">Therapy</th></tr><tr data-name="OPT_ID_493" data-para="true"><th data-name="OPT_ID_494" data-align="center" data-para="true">M-CLL</th><th data-name="OPT_ID_495" data-align="center" data-para="true">U-CLL</th><th data-name="OPT_ID_496" data-align="center" data-para="true">0</th><th data-name="OPT_ID_497" data-align="center" data-para="true">I,II</th><th data-name="OPT_ID_498" data-align="center" data-para="true">III, IV</th><th data-name="OPT_ID_499" colspan="2" data-align="center" data-para="true">High risk</th><th data-name="OPT_ID_500" colspan="2" data-align="center" data-para="true">Others</th><th data-name="OPT_ID_501" data-align="center" data-para="true">Treated</th><th data-name="OPT_ID_502" data-align="center" data-para="true">Untreated</th></tr></thead><tbody data-name="OPT_ID_503" data-attr-valign="top" data-para="true"><tr data-name="OPT_ID_504" data-para="true"><td data-name="OPT_ID_505" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_506">CXCL12</span></td><td data-name="OPT_ID_507" data-para="true"></td><td data-name="OPT_ID_508" data-para="true"></td><td data-name="OPT_ID_509" data-para="true"></td><td data-name="OPT_ID_510" data-para="true"></td><td data-name="OPT_ID_511" data-para="true"></td><td data-name="OPT_ID_512" data-para="true"></td><td data-name="OPT_ID_513" colspan="2" data-para="true"></td><td data-name="OPT_ID_514" colspan="2" data-para="true"></td><td data-name="OPT_ID_515" data-para="true"></td></tr><tr data-name="OPT_ID_516" data-para="true"><td data-name="OPT_ID_517" data-para="true"><span data-html-name="unicode-char"> </span>% of Control, median (N)</td><td data-name="OPT_ID_518" data-attr-char="(" data-align="char" data-para="true">31 (16)</td><td data-name="OPT_ID_519" data-attr-char="(" data-align="char" data-para="true">26 (11)</td><td data-name="OPT_ID_520" data-attr-char="(" data-align="char" data-para="true">26 (10)</td><td data-name="OPT_ID_521" data-attr-char="(" data-align="char" data-para="true">34 (8)</td><td data-name="OPT_ID_522" data-attr-char="(" data-align="char" data-para="true">34 (9)</td><td data-name="OPT_ID_523" data-attr-char="(" data-align="char" data-para="true">24 (6)</td><td data-name="OPT_ID_524" data-attr-char="(" colspan="2" data-align="char" data-para="true">34 (21)</td><td data-name="OPT_ID_525" data-attr-char="(" colspan="2" data-align="char" data-para="true">32 (13)</td><td data-name="OPT_ID_526" data-attr-char="(" data-align="char" data-para="true">30 (14)</td></tr><tr data-name="OPT_ID_527" data-para="true"><td data-name="OPT_ID_528" data-para="true"><span data-format="italic" data-actor="org" data-name="OPT_ID_529"><span data-html-name="unicode-char"> </span>P</span><cite data-standard-html-version="1.0" data-html-name="fn" data-attr-ref-type="table-fn" data-name="OPT_ID_530"><span data-history="original" data-attr-rid="TF1-1">*</span></cite></td><td data-name="OPT_ID_531" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_532">&lt; .0001</span></td><td data-name="OPT_ID_533" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_534">.0029</span></td><td data-name="OPT_ID_535" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_536">.002</span></td><td data-name="OPT_ID_537" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_538">.0015</span></td><td data-name="OPT_ID_539" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_540">.0117</span></td><td data-name="OPT_ID_541" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_542">.0014</span></td><td data-name="OPT_ID_543" data-attr-char="." colspan="2" data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_544">&lt;.0001</span></td><td data-name="OPT_ID_545" data-attr-char="." colspan="2" data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_546">.0002</span></td><td data-name="OPT_ID_547" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_548">.0002</span></td></tr><tr data-name="OPT_ID_549" data-para="true"><td data-name="OPT_ID_550" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_551">CCL19</span></td><td data-name="OPT_ID_552" data-para="true"></td><td data-name="OPT_ID_553" data-para="true"></td><td data-name="OPT_ID_554" data-para="true"></td><td data-name="OPT_ID_555" data-para="true"></td><td data-name="OPT_ID_556" data-para="true"></td><td data-name="OPT_ID_557" data-para="true"></td><td data-name="OPT_ID_558" colspan="2" data-para="true"></td><td data-name="OPT_ID_559" colspan="2" data-para="true"></td><td data-name="OPT_ID_560" data-para="true"></td></tr><tr data-name="OPT_ID_561" data-para="true"><td data-name="OPT_ID_562" data-para="true"><span data-html-name="unicode-char"> </span>% of Control, median (N)</td><td data-name="OPT_ID_563" data-attr-char="(" data-align="char" data-para="true">34 (16)</td><td data-name="OPT_ID_564" data-attr-char="(" data-align="char" data-para="true">29 (11)</td><td data-name="OPT_ID_565" data-attr-char="(" data-align="char" data-para="true">30 (10)</td><td data-name="OPT_ID_566" data-attr-char="(" data-align="char" data-para="true">40 (8)</td><td data-name="OPT_ID_567" data-attr-char="(" data-align="char" data-para="true">29 (9)</td><td data-name="OPT_ID_568" data-attr-char="(" data-align="char" data-para="true">26 (6)</td><td data-name="OPT_ID_569" data-attr-char="(" colspan="2" data-align="char" data-para="true">33 (21)</td><td data-name="OPT_ID_570" data-attr-char="(" colspan="2" data-align="char" data-para="true">28 (13)</td><td data-name="OPT_ID_571" data-attr-char="(" data-align="char" data-para="true">40 (14)</td></tr><tr data-name="OPT_ID_572" data-para="true"><td data-name="OPT_ID_573" data-para="true"><span data-format="italic" data-actor="org" data-name="OPT_ID_574"><span data-html-name="unicode-char"> </span>P</span><cite data-standard-html-version="1.0" data-html-name="fn" data-attr-ref-type="table-fn" data-name="OPT_ID_575"><span data-history="original" data-attr-rid="TF1-1">*</span></cite></td><td data-name="OPT_ID_576" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_577">.0042</span></td><td data-name="OPT_ID_578" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_579">.001</span></td><td data-name="OPT_ID_580" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_581">.0488</span></td><td data-name="OPT_ID_582" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_583">.004</span></td><td data-name="OPT_ID_584" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_585">.0117</span></td><td data-name="OPT_ID_586" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_587">.0023</span></td><td data-name="OPT_ID_588" data-attr-char="." colspan="2" data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_589">.0006</span></td><td data-name="OPT_ID_590" data-attr-char="." colspan="2" data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_591">.0012</span></td><td data-name="OPT_ID_592" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_593">.004</span></td></tr><tr data-name="OPT_ID_594" data-para="true"><td data-name="OPT_ID_595" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_596">BM stroma</span></td><td data-name="OPT_ID_597" data-para="true"></td><td data-name="OPT_ID_598" data-para="true"></td><td data-name="OPT_ID_599" data-para="true"></td><td data-name="OPT_ID_600" data-para="true"></td><td data-name="OPT_ID_601" data-para="true"></td><td data-name="OPT_ID_602" data-para="true"></td><td data-name="OPT_ID_603" colspan="2" data-para="true"></td><td data-name="OPT_ID_604" colspan="2" data-para="true"></td><td data-name="OPT_ID_605" data-para="true"></td></tr><tr data-name="OPT_ID_606" data-para="true"><td data-name="OPT_ID_607" data-para="true"><span data-html-name="unicode-char"> </span>% of Control, median (N)</td><td data-name="OPT_ID_608" data-attr-char="(" data-align="char" data-para="true">32 (4)</td><td data-name="OPT_ID_609" data-attr-char="(" data-align="char" data-para="true">54 (11)</td><td data-name="OPT_ID_610" data-attr-char="(" data-align="char" data-para="true">53 (1)</td><td data-name="OPT_ID_611" data-attr-char="(" data-align="char" data-para="true">67 (6)</td><td data-name="OPT_ID_612" data-attr-char="(" data-align="char" data-para="true">26 (8)</td><td data-name="OPT_ID_613" data-attr-char="(" data-align="char" data-para="true">53 (7)</td><td data-name="OPT_ID_614" data-attr-char="(" colspan="2" data-align="char" data-para="true">46 (8)</td><td data-name="OPT_ID_615" data-attr-char="(" colspan="2" data-align="char" data-para="true">37 (13)</td><td data-name="OPT_ID_616" data-attr-char="(" data-align="char" data-para="true">65 (2)</td></tr><tr data-name="OPT_ID_617" data-para="true"><td data-name="OPT_ID_618" data-para="true"><span data-format="italic" data-actor="org" data-name="OPT_ID_619"><span data-html-name="unicode-char"> </span>P</span><cite data-standard-html-version="1.0" data-html-name="fn" data-attr-ref-type="table-fn" data-name="OPT_ID_620"><span data-history="original" data-attr-rid="TF1-1">*</span></cite></td><td data-name="OPT_ID_621" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_622">.0365</span></td><td data-name="OPT_ID_623" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_624">.002</span></td><td data-name="OPT_ID_625" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_626">-</span></td><td data-name="OPT_ID_627" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_628">.023</span></td><td data-name="OPT_ID_629" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_630">.0148</span></td><td data-name="OPT_ID_631" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_632">.0313</span></td><td data-name="OPT_ID_633" data-attr-char="." colspan="2" data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_634">.0041</span></td><td data-name="OPT_ID_635" data-attr-char="." colspan="2" data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_636">.0005</span></td><td data-name="OPT_ID_637" data-align="center" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_638">-</span></td></tr><tr data-name="OPT_ID_639" data-para="true"><td data-name="OPT_ID_640" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_641">ECM</span></td><td data-name="OPT_ID_642" data-para="true"></td><td data-name="OPT_ID_643" data-para="true"></td><td data-name="OPT_ID_644" data-para="true"></td><td data-name="OPT_ID_645" data-para="true"></td><td data-name="OPT_ID_646" data-para="true"></td><td data-name="OPT_ID_647" data-para="true"></td><td data-name="OPT_ID_648" colspan="2" data-para="true"></td><td data-name="OPT_ID_649" colspan="2" data-para="true"></td><td data-name="OPT_ID_650" data-para="true"></td></tr><tr data-name="OPT_ID_651" data-para="true"><td data-name="OPT_ID_652" data-para="true"><span data-html-name="unicode-char"> </span>% of Control, median (N)</td><td data-name="OPT_ID_653" data-attr-char="(" data-align="char" data-para="true">41 (6)</td><td data-name="OPT_ID_654" data-attr-char="(" data-align="char" data-para="true">45 (4)</td><td data-name="OPT_ID_655" data-attr-char="(" data-align="char" data-para="true">95 (1)</td><td data-name="OPT_ID_656" data-attr-char="(" data-align="char" data-para="true">50 (4)</td><td data-name="OPT_ID_657" data-attr-char="(" data-align="char" data-para="true">35 (5)</td><td data-name="OPT_ID_658" data-attr-char="(" data-align="char" data-para="true">21 (3)</td><td data-name="OPT_ID_659" data-attr-char="(" colspan="2" data-align="char" data-para="true">46 (7)</td><td data-name="OPT_ID_660" data-attr-char="(" colspan="2" data-align="char" data-para="true">36 (6)</td><td data-name="OPT_ID_661" data-attr-char="(" data-align="char" data-para="true">83<cite data-standard-html-version="1.0" data-html-name="fn" data-attr-ref-type="table-fn" data-name="OPT_ID_662"><span data-history="original" data-attr-rid="TF1-2"><span data-html-name="unicode-char">†</span></span></cite> (4)</td></tr><tr data-name="OPT_ID_663" data-para="true"><td data-name="OPT_ID_664" data-para="true"><span data-format="italic" data-actor="org" data-name="OPT_ID_665"><span data-html-name="unicode-char"> </span>P</span><cite data-standard-html-version="1.0" data-html-name="fn" data-attr-ref-type="table-fn" data-name="OPT_ID_666"><span data-history="original" data-attr-rid="TF1-1">*</span></cite></td><td data-name="OPT_ID_667" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_668">.0313</span></td><td data-name="OPT_ID_669" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_670">.0452</span></td><td data-name="OPT_ID_671" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_672">-</span></td><td data-name="OPT_ID_673" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_674">.0419</span></td><td data-name="OPT_ID_675" data-attr-char="." data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_676">.0133</span></td><td data-name="OPT_ID_677" data-attr-char="." data-align="char" data-para="true">0.0663</td><td data-name="OPT_ID_678" data-attr-char="." colspan="2" data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_679">.0117</span></td><td data-name="OPT_ID_680" data-attr-char="." colspan="2" data-align="char" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_681">.0313</span></td><td data-name="OPT_ID_682" data-attr-char="." data-align="char" data-para="true">0.2069</td></tr></tbody></table><div data-html-name="table-footnote" data-name="OPT_ID_683" data-para="true"><div data-html-name="legend" data-name="OPT_ID_684" data-attr-fn-type="other" data-para="true"><span data-html-name="para" data-name="OPT_ID_685" data-para="true">CLL patient samples analyzed in <cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_686"><span data-history="original" data-attr-rid="F2">Figure 2B-E</span></cite> were divided into groups based on their clinical and molecular characteristics. Stratification was based on IGHV mutational status (M-CLL and U-CLL); Rai stage at sampling (groups 0/I-II/III-IV; stage II and IV); hierarchical cytogenetics [high risk (del 11q and del 17p) vs others (del 13q, normal karyotype, tris 12)]; and prior therapy (treated vs untreated). For full data, see supplemental Figure 2E-H. Results are summarized for each group in the following format: median percentage of control, number of samples (N), and statistical significance (<span data-format="italic" data-actor="org" data-name="OPT_ID_687">P</span>). Raw data (migration index [MI] values, supplemental Figure 2A-D) were analyzed by Wilcoxon matched-pairs signed rank test or ratio paired Student <span data-format="italic" data-actor="org" data-name="OPT_ID_688">t</span> test according to the data distribution. Significant <span data-format="italic" data-actor="org" data-name="OPT_ID_689">P</span> values are shown in bold.</span></div><div data-html-name="table-fn" data-name="OPT_ID_690" data-attr-fn-type="other" data-attr-id="TF1-1" data-para="true"><span data-html-name="fn-label" data-name="OPT_ID_691" data-para="true">*</span><span data-html-name="para" data-name="OPT_ID_692" data-para="true">Control vs CK1 inhibitor treated MI; Wilcoxon matched-pairs signed rank test or ratio paired Student <span data-format="italic" data-actor="org" data-name="OPT_ID_693">t</span> test according to the data distribution.</span></div><div data-html-name="legend" data-name="OPT_ID_694" data-attr-fn-type="other" data-para="true"><span data-html-name="para" data-name="OPT_ID_695" data-para="true"><span data-html-name="unicode-char">†</span>Inhibition was significantly weaker compared with the other group.</span></div><div data-html-name="table-fn" data-name="OPT_ID_696" data-attr-fn-type="other" data-attr-id="TF1-2" data-para="true"><span data-html-name="fn-label" data-name="OPT_ID_697" data-para="true"><span data-html-name="unicode-char">†</span></span><span data-html-name="para" data-name="OPT_ID_698" data-para="true">Inhibitory effects were significantly different between groups.</span></div></div></div></section><section data-html-name="section" data-name="OPT_ID_699" data-para="true"><h3 data-html-name="section-title" aria-level="3" data-name="OPT_ID_700" data-para="true">CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibition blocks production of CCL3/4 by CLL cells in a coculture system</h3><div data-html-name="para" data-name="OPT_ID_701" data-para="true">Microenvironment can induce transcription of genes that help CLL cells to survive or shape their own environment, for example by production of T-cell chemokines CCL3 or CCL4 contributing to the formation of lymph node pseudofollicles.<span data-format="superscript" data-actor="org" data-name="OPT_ID_702"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_703"><span data-history="original" data-attr-rid="B31 B32">31,32</span></cite></span> In order to address this issue, we employed a double-species coculture system, where the primary human CLL cells interacted directly with the mouse BM stromal cells M210B4<span data-format="superscript" data-actor="org" data-name="OPT_ID_704"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_705"><span data-history="original" data-attr-rid="B21">21</span></cite></span> (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_706"><span data-history="original" data-attr-rid="F3">Figure 3A</span></cite>). These complex interactions resulted in a robust increase in the expression of <span data-format="italic" data-actor="org" data-name="OPT_ID_707">CCL3</span> and <span data-format="italic" data-actor="org" data-name="OPT_ID_708">CCL4</span> that could be quantified by human-specific quantitative polymerase chain reaction analysis, which allows for absolute control over specificity of the detected gene expression. In our cohort of 18 patient samples, 15 upregulated both <span data-format="italic" data-actor="org" data-name="OPT_ID_709">CCL3</span> and <span data-format="italic" data-actor="org" data-name="OPT_ID_710">CCL4</span> (defined as at least fivefold increase; median fold increase 211<span data-html-name="unicode-char">×</span> and 88<span data-html-name="unicode-char">×</span>, respectively) (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_711"><span data-history="original" data-attr-rid="F3">Figure 3B</span></cite>). Addition of CK1 inhibitor dose dependently reduced the induction of <span data-format="italic" data-actor="org" data-name="OPT_ID_712">CCL3</span> and <span data-format="italic" data-actor="org" data-name="OPT_ID_713">CCL4</span> expression in 4 analyzed CLL samples (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_714"><span data-history="original" data-attr-rid="F3">Figure 3C-D</span></cite>) with estimated EC<span data-format="subscript" data-actor="org" data-name="OPT_ID_715">50</span> values below 0.5 <span data-html-name="unicode-char">µ</span>M. The effects were confirmed on a larger number of patients (N = 15; <cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_716"><span data-history="original" data-attr-rid="F3">Figure 3E</span></cite>; supplemental Figure 3A-B) and further validated by human-specific enzyme-linked immunosorbent assay of CCL3 and CCL4 chemokines secreted to culture medium by CLL cells in this experimental set up (N = 3; <cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_717"><span data-history="original" data-attr-rid="F3">Figure 3F</span></cite>). CXCL12/CCL19 chemokines or fibronectin alone were not considered as suitable stimuli for this type of analysis, because their ability to induce <span data-format="italic" data-actor="org" data-name="OPT_ID_718">CCL3/4</span> expression in CLL cells was negligible compared with effects of M210B4 cells (supplemental Figure 3C). Overall, we provide evidence that CK1 activity is important also for cell-cell interactions and that CK1 inhibitor specifically blocks microenvironment-induced transcription in CLL cells.</div><figure data-html-name="figure" data-name="OPT_ID_719" data-attr-id="F3" data-para="true"><div class="wrapper" data-name="OPT_ID_733" data-para="true"><div class="container-image"><img src="https://pgc-dev-test.s3.amazonaws.com/13398/" class="imgrsize" width="" height="" data-height="" data-width="" data-id="OPT_ID_733" data-web-src="https://pgc-dev-test.s3.amazonaws.com/13398/" /></div></div><span data-html-name="label" data-name="OPT_ID_720" data-para="true">Figure 3.</span><span data-auto-generated="true"><span data-html-name="unicode-char"> </span></span><figcaption data-html-name="caption" data-name="OPT_ID_721" data-para="true"><div data-html-name="para" data-name="OPT_ID_722" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_723">CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibition blocks production of CCL3 and CCL4 by CLL cells in a coculture system.</span> (A) Scheme of coculture experiments. (B) Expression of human <span data-format="italic" data-actor="org" data-name="OPT_ID_724">CCL3</span> and <span data-format="italic" data-actor="org" data-name="OPT_ID_725">CCL4</span> was analyzed by quantitative reverse transcription polymerase chain reaction using human-specific primers in samples containing cocultured primary CLL and mouse stromal cells (N = 18). Relative change in the expression (with/without coculture) is shown. Columns represent median. (C-D) CK1 inhibitor treatment dose dependently (0.3-10 <span data-html-name="unicode-char">µ</span>M) inhibits the stroma-induced expression of <span data-format="italic" data-actor="org" data-name="OPT_ID_726">CCL3/4</span> in CLL cells. EC<span data-format="subscript" data-actor="org" data-name="OPT_ID_727">50</span> values were estimated by nonlinear fit method (log inhibitor vs response) based on 4 individual patient sample sets (6-hour coculture). (E) Effects of CK1 inhibition (10 <span data-html-name="unicode-char">µ</span>M PF-670462) on the stroma-induced expression of <span data-format="italic" data-actor="org" data-name="OPT_ID_728">CCL3</span> (i) and <span data-format="italic" data-actor="org" data-name="OPT_ID_729">CCL4</span> (ii) are shown as a relative expression change normalized to the untreated unstimulated control for each data set (6-hour coculture; <span data-format="italic" data-actor="org" data-name="OPT_ID_730">P</span> = .0002 and 0.0034, N = 15, Wilcoxon matched-pairs signed rank test). (F) Secreted chemokines CCL3 (i) and CCL4 (ii) were quantified by human-specific enzyme-linked immunosorbent assay in media harvested after 30 hours of incubation. No chemokines were detected in media harvested from mouse BM stromal cells or medium without cells (N = 3, <span data-format="italic" data-actor="org" data-name="OPT_ID_731">P</span> &lt; .05, ratio paired Student <span data-format="italic" data-actor="org" data-name="OPT_ID_732">t</span> test).</div></figcaption></figure></section><section data-html-name="section" data-name="OPT_ID_734" data-para="true"><h3 data-html-name="section-title" aria-level="3" data-name="OPT_ID_735" data-para="true">CK1 inhibitor PF-670462 delays development of leukemia in the E<span data-html-name="unicode-char">µ</span>-TCL1 adoptive transfer (AT) model of CLL</h3><div data-html-name="para" data-name="OPT_ID_736" data-para="true">Results of the in vitro assays, together with published data,<span data-format="superscript" data-actor="org" data-name="OPT_ID_737"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_738"><span data-history="original" data-attr-rid="B27 B28 B33 B34">27,28,33,34</span></cite></span> indicated that PF-670462 is a compound suitable for further in vivo experiments. It is well tolerated and has good pharmacokinetic properties, reaching micromolar concentrations (effective in the in vitro assays) in plasma.<span data-format="superscript" data-actor="org" data-name="OPT_ID_739"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_740"><span data-history="original" data-attr-rid="B27">27</span></cite></span> We have decided to test this inhibitor in an AT model of murine E<span data-html-name="unicode-char">µ</span>-TCL1 leukemia, commonly used for preclinical testing of novel candidate drugs for CLL.<span data-format="superscript" data-actor="org" data-name="OPT_ID_741"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_742"><span data-history="original" data-attr-rid="B12 B35 B36 B37">12,35-37</span></cite></span> The Gene Expression Omnibus database<span data-format="superscript" data-actor="org" data-name="OPT_ID_743"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_744"><span data-history="original" data-attr-rid="B38 B39">38,39</span></cite></span> showed that <span data-format="italic" data-actor="org" data-name="OPT_ID_745">csnk1e</span> is expressed also in the case of leukemic B cells isolated from the E<span data-html-name="unicode-char">µ</span>-TCL1 transgenic mice<span data-format="superscript" data-actor="org" data-name="OPT_ID_746"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_747"><span data-history="original" data-attr-rid="B23">23</span></cite></span> (accession number GSE60925<span data-format="superscript" data-actor="org" data-name="OPT_ID_748"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_749"><span data-history="original" data-attr-rid="B40">40</span></cite></span>) (supplemental Figure 4A), which suggests that these mice are a good model for analysis of CK1 inhibitors. To make sure that we effectively inhibit CK1<span data-html-name="unicode-char">ε</span> in leukemic cells in vivo, we performed CK1<span data-html-name="unicode-char">ε</span> autophosphorylation assay on primary PB WBCs isolated from PB of &gt;12-month-old E<span data-html-name="unicode-char">µ</span>-TCL1 mice with progressed leukemia. This analysis showed that intraperitoneal injection of PF-670462 (10, 30, and 60 mg/kg) translates into a dose-dependent inhibition of CK1<span data-html-name="unicode-char">ε</span> activity in vivo (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_750"><span data-history="original" data-attr-rid="F4">Figure 4A</span></cite>). The in vivo effects were long lasting (up to 10 hours) as confirmed by the analysis of DVL3 phosphorylation, a sensitive marker of CK1<span data-html-name="unicode-char">ε</span> activity (supplemental Figure 4B), in the colon samples of WT mice treated with 30 mg/kg dose (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_751"><span data-history="original" data-attr-rid="F4">Figure 4B</span></cite>). Comparable effects were seen for intraperitoneal administration and administration by mouth (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_752"><span data-history="original" data-attr-rid="F4">Figure 4B</span></cite>).</div><figure data-html-name="figure" data-name="OPT_ID_753" data-attr-id="F4" data-para="true"><div class="wrapper" data-name="OPT_ID_768" data-para="true"><div class="container-image"><img src="https://pgc-dev-test.s3.amazonaws.com/13398/" class="imgrsize" width="" height="" data-height="" data-width="" data-id="OPT_ID_768" data-web-src="https://pgc-dev-test.s3.amazonaws.com/13398/" /></div></div><span data-html-name="label" data-name="OPT_ID_754" data-para="true">Figure 4.</span><span data-auto-generated="true"><span data-html-name="unicode-char"> </span></span><figcaption data-html-name="caption" data-name="OPT_ID_755" data-para="true"><div data-html-name="para" data-name="OPT_ID_756" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_757">CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibitor PF-670462 delays development of leukemia in the E<span data-html-name="unicode-char">µ</span>-TCL1 AT model of CLL.</span> (A) In vivo CK1<span data-html-name="unicode-char">ε</span> activity was assayed in primary PB WBCs isolated from E<span data-html-name="unicode-char">µ</span>-TCL1 mice with advanced spontaneous leukemia, which had been injected intraperitoneally by indicated doses of CK1 inhibitor. PB samples were taken 2 hours after the administration and processed by red blood cell (RBC) lysis and subsequent stimulation by 50 nM Calyculin A (10 minutes, 37<span data-html-name="unicode-char">°</span>C), followed by cell lysis and western blotting analysis. (B) Activity of the CK1 inhibitor in vivo at time points 3 to 14 hours after administration was assessed by analysis of DVL3 phosphorylation status in the colon tissue of wild-type (WT) mice. The inhibitor was administered as 30 mg/kg (i.p., intraperitoneal; p.o., peroral = oral gavage), solvent only was used as a control (i.p.). DVL3 phosphorylation is a sensitive marker of CK1<span data-html-name="unicode-char">ε</span> activity (see supplemental Figure 4B). (C) Typical disease progression in the AT leukemia model (N = 23). Day 0 = WT reference values (N = 16). Values are presented as means <span data-html-name="unicode-char">±</span> SEM. (Di) Scheme of experiment. (Dii) PF-670462 [21 days of treatment, administered by i.p. (N = 9) or by oral gavage (N = 6), control N = 8] reduces progression of CLL presented as lower WBC counts in the CK1 inhibitor treated group (unpaired Student <span data-format="italic" data-actor="org" data-name="OPT_ID_758">t</span> test, <span data-format="italic" data-actor="org" data-name="OPT_ID_759">P</span> = .0003). Merged data from 3 (i.p.) or 2 (oral gavage) independent experiments are presented. (Diii) The effect is evident also after 20 days treatment-free follow-up (<span data-format="italic" data-actor="org" data-name="OPT_ID_760">P</span> = .0435). Gray lines indicate median. (E) Scheme of experiment analyzed in panels F through H. (F) Results of regular PB sampling of the experiment schematized in panel E. Values represent means <span data-html-name="unicode-char">±</span> SEM. Unpaired Student <span data-format="italic" data-actor="org" data-name="OPT_ID_761">t</span> test was used to compare CK1 inhibitor treated (N = 9) and control (N = 11) groups at indicated time points. (G) Spleen infiltration was measured by ultrasound after the end of inhibitor treatment (day 50; unpaired Student <span data-format="italic" data-actor="org" data-name="OPT_ID_762">t</span> test, <span data-format="italic" data-actor="org" data-name="OPT_ID_763">P</span> = .0183). Columns represent <cite data-standard-html-version="1.0" data-html-name="eqn" data-attr-ref-type="disp-formula" data-name="OPT_ID_764"><span data-history="original" data-attr-rid="eq3 eq4">Eq. <span data-format="bold" data-actor="org" data-name="OPT_ID_765">3</span> and Eq. <span data-format="bold" data-actor="org" data-name="OPT_ID_766">4</span></span></cite> median value. (H) Mice were scored for overall survival (<span data-format="italic" data-actor="org" data-name="OPT_ID_767">P</span> = .027, Gehan-Breslow-Wilcoxon test). The x-axis presents the treatment-free period of the experiment, starting by day 50 (end of treatment).</div></figcaption></figure><div data-html-name="para" data-name="OPT_ID_769" data-para="true">In AT experiments, leukemic cells gradually accumulate in PB (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_770"><span data-history="original" data-attr-rid="F4">Figure 4C</span></cite>) and can be easily detected by flow cytometric analysis of PB samples because of a specific phenotype, CD5<span data-format="superscript" data-actor="org" data-name="OPT_ID_771">low</span>CD45R<span data-format="superscript" data-actor="org" data-name="OPT_ID_772">low12</span> (supplemental Figure 4C-D). In our initial AT experiment (schematized in Fig. 4Di),<span data-html-name="display-formula" data-name="OPT_ID_773" data-attr-id="eq3" data-para="true"><span data-html-name="math" data-current-version="1" data-standard-html-version="1.0" data-math-mode="editable" data-name="OPT_ID_774" data-math-type="display-numbered"><span data-version="1"><span data-name="mathml"><math altimg="me3.gif" data-name="OPT_ID_774" data-attr-display="block" data-attr-id="me3"><mrow optname="OPT_ID_775"><msub optname="OPT_ID_776"><mi optname="OPT_ID_777">C</mi><mi optname="OPT_ID_778">T</mi></msub><mrow optname="OPT_ID_779"><mfenced open="(" close=")"><mrow><mrow optname="OPT_ID_781"><mi mathvariant="normal" optname="OPT_ID_782">Δ</mi><mi optname="OPT_ID_783">j</mi></mrow></mrow></mfenced></mrow><mi mathvariant="normal" optname="OPT_ID_785">=</mi><mrow optname="OPT_ID_786"><mrow optname="OPT_ID_787"><msub optname="OPT_ID_788"><mrow optname="OPT_ID_789"><mrow optname="OPT_ID_790"><mo optname="OPT_ID_791">〈</mo><mrow optname="OPT_ID_792"><mi optname="OPT_ID_793">σ</mi><mrow optname="OPT_ID_794"><mfenced open="(" close=")"><mrow><mrow optname="OPT_ID_796"><mi optname="OPT_ID_797">i</mi><mo optname="OPT_ID_798">,</mo><mi optname="OPT_ID_799">j</mi></mrow></mrow></mfenced></mrow><mi optname="OPT_ID_801">σ</mi><mrow optname="OPT_ID_802"><mfenced open="(" close=")"><mrow><mrow optname="OPT_ID_804"><mi optname="OPT_ID_805">i</mi><mo optname="OPT_ID_806">,</mo><mi optname="OPT_ID_807">j</mi><mo optname="OPT_ID_808">+</mo><mi mathvariant="normal" optname="OPT_ID_809">Δ</mi><mi optname="OPT_ID_810">j</mi></mrow></mrow></mfenced></mrow></mrow><mo optname="OPT_ID_812">〉</mo></mrow></mrow><mi optname="OPT_ID_813">c</mi></msub></mrow><mo optname="OPT_ID_814">/</mo><mrow optname="OPT_ID_815"><msub optname="OPT_ID_816"><mrow optname="OPT_ID_817"><mrow optname="OPT_ID_818"><mo optname="OPT_ID_819">〈</mo><mrow optname="OPT_ID_820"><mi optname="OPT_ID_821">σ</mi><mrow optname="OPT_ID_822"><mfenced open="(" close=")"><mrow><mrow optname="OPT_ID_824"><mi optname="OPT_ID_825">i</mi><mo optname="OPT_ID_826">,</mo><mi optname="OPT_ID_827">j</mi></mrow></mrow></mfenced></mrow><mi optname="OPT_ID_829">σ</mi><mrow optname="OPT_ID_830"><mfenced open="(" close=")"><mrow><mrow optname="OPT_ID_832"><mi optname="OPT_ID_833">i</mi><mo optname="OPT_ID_834">,</mo><mi optname="OPT_ID_835">j</mi></mrow></mrow></mfenced></mrow></mrow><mo optname="OPT_ID_837">〉</mo></mrow></mrow><mi optname="OPT_ID_838">c</mi></msub></mrow></mrow><mo optname="OPT_ID_839">,</mo></mrow></math></span></span></span><span data-html-name="math-label" data-name="OPT_ID_840" data-para="true">[3]</span></span><span data-html-name="display-formula" data-name="OPT_ID_841" data-attr-id="eq4" data-para="true"><span data-html-name="math" data-current-version="1" data-standard-html-version="1.0" data-math-mode="editable" data-name="OPT_ID_842" data-math-type="display-numbered"><span data-version="1"><span data-name="mathml"><math altimg="me4.gif" data-name="OPT_ID_842" data-attr-display="block" data-attr-id="me4"><mrow optname="OPT_ID_843"><msub optname="OPT_ID_844"><mi optname="OPT_ID_845">C</mi><mi optname="OPT_ID_846">L</mi></msub><mrow optname="OPT_ID_847"><mfenced open="(" close=")"><mrow><mrow optname="OPT_ID_849"><mi mathvariant="normal" optname="OPT_ID_850">Δ</mi><mi optname="OPT_ID_851">i</mi></mrow></mrow></mfenced></mrow><mo optname="OPT_ID_853">=</mo><mrow optname="OPT_ID_854"><mrow optname="OPT_ID_855"><msub optname="OPT_ID_856"><mrow optname="OPT_ID_857"><mrow optname="OPT_ID_858"><mo optname="OPT_ID_859">〈</mo><mrow optname="OPT_ID_860"><mi optname="OPT_ID_861">σ</mi><mrow optname="OPT_ID_862"><mfenced open="(" close=")"><mrow><mrow optname="OPT_ID_864"><mi optname="OPT_ID_865">i</mi><mo optname="OPT_ID_866">,</mo><mi optname="OPT_ID_867">j</mi></mrow></mrow></mfenced></mrow><mi optname="OPT_ID_869">σ</mi><mrow optname="OPT_ID_870"><mfenced open="(" close=")"><mrow><mrow optname="OPT_ID_872"><mi optname="OPT_ID_873">i</mi><mo optname="OPT_ID_874">+</mo><mi mathvariant="normal" optname="OPT_ID_875">Δ</mi><mi optname="OPT_ID_876">i</mi><mo optname="OPT_ID_877">,</mo><mi optname="OPT_ID_878">j</mi></mrow></mrow></mfenced></mrow></mrow><mo optname="OPT_ID_880">〉</mo></mrow></mrow><mi optname="OPT_ID_881">c</mi></msub></mrow><mo optname="OPT_ID_882">/</mo><mrow optname="OPT_ID_883"><msub optname="OPT_ID_884"><mrow optname="OPT_ID_885"><mrow optname="OPT_ID_886"><mo optname="OPT_ID_887">〈</mo><mrow optname="OPT_ID_888"><mi optname="OPT_ID_889">σ</mi><mrow optname="OPT_ID_890"><mfenced open="(" close=")"><mrow><mrow optname="OPT_ID_892"><mi optname="OPT_ID_893">i</mi><mo optname="OPT_ID_894">,</mo><mi optname="OPT_ID_895">j</mi></mrow></mrow></mfenced></mrow><mi optname="OPT_ID_897">σ</mi><mrow optname="OPT_ID_898"><mfenced open="(" close=")"><mrow><mrow optname="OPT_ID_900"><mi optname="OPT_ID_901">i</mi><mo optname="OPT_ID_902">,</mo><mi optname="OPT_ID_903">j</mi></mrow></mrow></mfenced></mrow></mrow><mo optname="OPT_ID_905">〉</mo></mrow></mrow><mi optname="OPT_ID_906">c</mi></msub></mrow></mrow><mo optname="OPT_ID_907">,</mo></mrow></math></span></span></span><span data-html-name="math-label" data-name="OPT_ID_908" data-para="true">[4]</span></span> we treated mice with water dissolved PF-670462 CK1 inhibitor for 21 days with 60 mg/kg per 2 days (intraperitoneally) or by 30 mg/kg per day (by mouth, oral gavage) and demonstrated that PF-670462 is able to reduce progression of CLL both immediately after the end of treatment (Figure 4Dii) and after 20 days of treatment-free follow-up (Figure 4Diii).</div><div data-html-name="para" data-name="OPT_ID_909" data-para="true">In the second experimental setup (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_910"><span data-history="original" data-attr-rid="F4">Figure 4E</span></cite>) the treatment period was prolonged to 50 days and the drug was administered daily by oral gavage at 30 mg/kg/day. The disease progression was monitored weekly by PB sampling (starting at day 21) and spleen ultrasound (supplemental Figure 4E-G) and was scored for overall survival. In this setup, PF-670462<span data-html-name="unicode-char">–</span>treated animals showed significantly lower WBC counts (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_911"><span data-history="original" data-attr-rid="F4">Figure 4F</span></cite>) and lower leukemic cell counts (supplemental Figure 4H), leukemic cell proportion (supplemental Figure 4I), and spleen volume determined by ultrasound (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_912"><span data-history="original" data-attr-rid="F4">Figure 4G</span></cite>) when compared with the control mice. Follow-up monitoring further showed that PF-670462<span data-html-name="unicode-char">–</span>treated mice lived significantly longer compared with the control group (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_913"><span data-history="original" data-attr-rid="F4">Figure 4H</span></cite>). However, after the end of the treatment (day 50), fast progression was observed resulting in a relatively small difference in the median overall survival (92 vs 85 days after cell transplantation). The spleen and liver size did not differ in the dead animals (supplemental Figure 4J), indicating that indeed the mice died when they reached the final stage of the disease. No obvious side effects of the treatment were detected.</div></section><section data-html-name="section" data-name="OPT_ID_914" data-para="true"><h3 data-html-name="section-title" aria-level="3" data-name="OPT_ID_915" data-para="true">PF-670462 delays leukemic onset in the spontaneous E<span data-html-name="unicode-char">µ</span>-TCL1<span data-html-name="unicode-char">–</span>induced murine CLL</h3><div data-html-name="para" data-name="OPT_ID_916" data-para="true">To further assess the potential of PF-670462, we have analyzed its effects in the model of spontaneous E<span data-html-name="unicode-char">µ</span>-TCL1 leukemia (for typical progression in our hands, see <cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_917"><span data-history="original" data-attr-rid="F5">Figure 5A</span></cite>; supplemental Figure 5A), which reflects closely the disease development in humans.<span data-format="superscript" data-actor="org" data-name="OPT_ID_918"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_919"><span data-history="original" data-attr-rid="B41">41</span></cite></span> In this model, leukemia appears spontaneously, in the presence of complete microenvironment and fully functional immune system. This enables to study the disease in its full complexity, taking into account the effects of an inhibitor on microenvironmental communication of leukemic cells.</div><figure data-html-name="figure" data-name="OPT_ID_920" data-attr-id="F5" data-para="true"><div class="wrapper" data-name="OPT_ID_936" data-para="true"><div class="container-image"><img src="https://pgc-dev-test.s3.amazonaws.com/13398/" class="imgrsize" width="" height="" data-height="" data-width="" data-id="OPT_ID_936" data-web-src="https://pgc-dev-test.s3.amazonaws.com/13398/" /></div></div><span data-html-name="label" data-name="OPT_ID_921" data-para="true">Figure 5.</span><span data-auto-generated="true"><span data-html-name="unicode-char"> </span></span><figcaption data-html-name="caption" data-name="OPT_ID_922" data-para="true"><div data-html-name="para" data-name="OPT_ID_923" data-para="true"><span data-format="bold" data-actor="org" data-name="OPT_ID_924">CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibitor PF-670462 delays leukemic onset in the E<span data-html-name="unicode-char">µ</span>-TCL1 transgenic mouse model of CLL.</span> (A) Typical disease development in the model used in panels B through G. (B) Scheme of experiment. (C) Delay in the leukemia onset in the case of CK1 inhibitor treated group is presented as a difference in WBC counts. Only mice in the control group (N = 16) significantly progressed between months 6 and 7 (<span data-format="italic" data-actor="org" data-name="OPT_ID_925">P</span> = .0036, paired Student <span data-format="italic" data-actor="org" data-name="OPT_ID_926">t</span> test); CK1 inhibitor treated mice: N = 13, paired Student <span data-format="italic" data-actor="org" data-name="OPT_ID_927">t</span> test. The WBC counts were significantly different between groups after the treatment period (<span data-format="italic" data-actor="org" data-name="OPT_ID_928">P</span> = .0030, unpaired Student <span data-format="italic" data-actor="org" data-name="OPT_ID_929">t</span> test). Results from 2 independent experiments were merged together. WBC (normalized value): 0% = the lowest value in each data set; 100% = the highest value in each data set. Columns represent median. (D) Repeated treatment by the CK1 inhibitor at months 6 to 7 and 10 to 11 significantly delays progression of the disease, measured as a ratio of mice with highly progressed stage/dead mice vs mice with early stage of the disease in time (<span data-format="italic" data-actor="org" data-name="OPT_ID_930">P</span> = .0142, <span data-html-name="unicode-char">χ</span><span data-format="superscript" data-actor="org" data-name="OPT_ID_931">2</span> test). Dead of leukemia refers to mice that had enlarged spleen and had detectable progressed leukemia at the last PB sampling before death. (E) The inhibitor-treated mice lived significantly longer compared with the control group (N = 13 treated vs 16 control animals, experiments 1 and 2 merged; <span data-format="italic" data-actor="org" data-name="OPT_ID_932">P</span> = .0257, log-rank test). Overall survival is presented starting from the sixth month = start of the first treatment cycle. (F) Organ sizes were analyzed at the end of the experiment or at the time of death. WT, age-matched nontransgenic wild-type C57BL/6 littermates. (Fi) Spleens of the inhibitor treated mice were significantly smaller compared with the control group (N = 12 treated, 13 control and 3 WT animals, <span data-format="italic" data-actor="org" data-name="OPT_ID_933">P</span> = .0114, Mann-Whitney <span data-format="italic" data-actor="org" data-name="OPT_ID_934">U</span> test). (Fii) Examples of the spleens obtained by autopsy. (Fiii) A similar but not significant trend was noted in liver. Columns represent median. (G) PB analysis by hemoanalyzer was performed on 7 CK1 inhibitor treated mice and 4 control mice after the end of the survival analysis (experimental data set 1). The inhibitor treated mice were significantly less anemic, which is indicated by higher RBC counts (i) and hemoglobin (ii; HGB) or hematocrit (iii; HCT) levels compared with the control animals, close to WT littermates (N = 6). (iv) Plateletcrit (PCT) was not increased by treatment. Unpaired Student <span data-format="italic" data-actor="org" data-name="OPT_ID_935">t</span> test was used. Values are presented as mean <span data-html-name="unicode-char">±</span> SEM.</div></figcaption></figure><div data-html-name="para" data-name="OPT_ID_937" data-para="true">Using this model, we performed 2 30-day cycles of PF-670462 treatment (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_938"><span data-history="original" data-attr-rid="F5">Figure 5B</span></cite>). The first treatment (PF-670462 at 60 mg/kg per 2 days, intraperitoneally) was administered for 30 days at the age of 6 months when animals showed early B-cell leukemia. In 2 independent experiments (in total N = 16 for control group and N = 13 for inhibitor-treated animals), the inhibitor-treated mice showed slower progression of the disease after the first cycle (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_939"><span data-history="original" data-attr-rid="F5">Figure 5C</span></cite>; for individual experiments, see supplemental Figure 5B). The second treatment cycle was applied 3 months later, and mice were assessed by a simple staging system, which showed that PF-670462 was able to significantly slow down the disease progression (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_940"><span data-history="original" data-attr-rid="F5">Figure 5D</span></cite>).</div><div data-html-name="para" data-name="OPT_ID_941" data-para="true">Most importantly, follow-up of these animals showed that PF-670462<span data-html-name="unicode-char">–</span>treated mice survived significantly longer (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_942"><span data-history="original" data-attr-rid="F5">Figure 5E</span></cite>). Surviving mice were euthanized, and their PB and organs were analyzed. We have observed significantly larger spleens in the control-treated mice compared with the animals receiving PF-670462 (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_943"><span data-history="original" data-attr-rid="F5">Figure 5Fi-ii</span></cite>). A similar trend, albeit not significant, was observed also in the liver size (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_944"><span data-history="original" data-attr-rid="F5">Figure 5Fiii</span></cite>). Hematological analysis of PB after the second treatment cycle showed significantly lower RBC counts, hematocrit, or hemoglobin levels in PB of the control mice compared with the inhibitor-treated mice (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_945"><span data-history="original" data-attr-rid="F5">Figure 5G</span></cite>; supplemental Figure 5C). Moreover, these levels were comparable to the age-matched untreated wild-type C57BL/6 littermates, suggesting that PF-670462 can efficiently prevent onset of anemia, likely caused by BM infiltration by leukemic cells. Of note, the treatment with PF-670462 had no adverse effects on normal hematopoiesis in the age-matched wild-type animals (supplemental Figure 5C-D).</div></section><section data-html-name="section" data-name="OPT_ID_946" data-para="true"><h3 data-html-name="section-title" aria-level="3" data-name="OPT_ID_947" data-para="true">CK1 inhibition potentiates effects of ibrutinib in vitro and in vivo</h3><div data-html-name="para" data-name="OPT_ID_948" data-para="true">The role of the BCR signaling pathway in CLL pathogenesis has been well described and is documented by the efficacy of BCR inhibitors, such as the BTK inhibitor ibrutinib, in CLL treatment.<span data-format="superscript" data-actor="org" data-name="OPT_ID_949"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_950"><span data-history="original" data-attr-rid="B42">42</span></cite></span> An existing rationale based on targeting the ROR1 receptor suggests that combined targeting of Wnt/PCP and BCR signaling in CLL can be beneficial.<span data-format="superscript" data-actor="org" data-name="OPT_ID_951"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_952"><span data-history="original" data-attr-rid="B43 B44">43,44</span></cite></span> Therefore, we next addressed the question of whether CK1 inhibition further adds to the effects of ibrutinib when used in combination (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_953"><span data-history="original" data-attr-rid="F6">Figure 6A</span></cite>). To rule out the possibility that PF-670462 and ibrutinib cross-react (ie, PF-670462 inhibits the BCR pathway or ibrutinib inhibits CK1), we have performed analysis of signaling activity in primary CLL cells. CK1<span data-html-name="unicode-char">ε</span> autophosphorylation assay (N = 3; <cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_954"><span data-history="original" data-attr-rid="F6">Figure 6B</span></cite>) showed that ibrutinib has no effect on CK1<span data-html-name="unicode-char">ε</span> activity, and BCR-activation assay triggered by anti<span data-html-name="unicode-char">–</span>immunoglobulin M (N = 4; <cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_955"><span data-history="original" data-attr-rid="F6">Figure 6C</span></cite>) showed that PF-670462 in the tested conditions does not affect the activity of the BCR signaling pathway measured as the phosphorylation of BTK, PLC<span data-html-name="unicode-char">γ</span>2, SYK, or extracellular signal-regulated kinase 1/2 (for quantification, see <cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_956"><span data-history="original" data-attr-rid="F6">Figure 6D-E</span></cite> and supplemental Figure 6A-C).</div><div data-html-name="para" data-name="OPT_ID_957" data-para="true">Both PF-670462 (this study) and ibrutinib were described to inhibit chemotaxis of primary CLL cells.<span data-format="superscript" data-actor="org" data-name="OPT_ID_958"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_959"><span data-history="original" data-attr-rid="B7 B45">7,45</span></cite></span> With this in mind, we analyzed chemotactic capacity of primary CLL cells cotreated with PF-670462 and 0.1 <span data-html-name="unicode-char">μ</span>M ibrutinib (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_960"><span data-history="original" data-attr-rid="F6">Figure 6F</span></cite>; supplemental Figure 6D-F). This dose of ibrutinib showed basically complete BTK inhibition (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_961"><span data-history="original" data-attr-rid="F6">Figure 6C</span></cite>) without direct toxicity in the 6-hour treatment as a single agent (supplemental Figure 6G) or in combination (supplemental Figure 6F,H). In the case of a single-agent treatment, we observed significant decrease in the chemotaxis toward both CCL19 and CXCL12 after CK1 inhibition; ibrutinib treatment reduced chemotaxis toward CCL19 only (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_962"><span data-history="original" data-attr-rid="F6">Figure 6F</span></cite>; supplemental Figure 6D-E). Importantly, the combination of CK1 inhibitor and ibrutinib was the most effective. We further explored nature of these combinatory effects using isobolographic analysis based on CCL19-induced transwell migration data (N = 3) with 0.03 to 1 <span data-html-name="unicode-char">µ</span>M dose response for ibrutinib and 0.03 to 10 <span data-html-name="unicode-char">µ</span>M for PF-670462. Results confirmed that the effect on migration is synergistic (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_963"><span data-history="original" data-attr-rid="F6">Figure 6G</span></cite>; supplemental Figure 6I) despite some variability among patients (supplemental Figure 6J).</div><div data-html-name="para" data-name="OPT_ID_964" data-para="true">These data suggest that targeting both Wnt/PCP and BCR pathways via CK1 inhibition might be in principle beneficial as suggested recently by others.<span data-format="superscript" data-actor="org" data-name="OPT_ID_965"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_966"><span data-history="original" data-attr-rid="B43 B44">43,44</span></cite></span> In order to test this assumption, we performed another in vivo AT experiment as described in <cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_967"><span data-history="original" data-attr-rid="F4">Figure 4</span></cite>. In this case, the mice were divided into 5 groups: 8 mice were not transplanted and served as a reference; all the other mice were transplanted by leukemic cells and treated with CK1 inhibitor, ibrutinib, or combination (8 mice each group) or solvent as a control (6 mice). All drugs were dissolved in kolliphor in order to administer the same solvent. Mice were treated for 42 days with 30 mg/kg per day (by mouth, both compounds), and their PB was regularly sampled (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_968"><span data-history="original" data-attr-rid="F6">Figure 6H</span></cite>). On the day 38, ultrasound measurement was performed (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_969"><span data-history="original" data-attr-rid="F6">Figure 6I</span></cite>). Both analyses confirmed previous findings about significant effects of CK1 inhibitor and ibrutinib<span data-format="superscript" data-actor="org" data-name="OPT_ID_970"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_971"><span data-history="original" data-attr-rid="B36 B46">36,46</span></cite></span> as a single treatment; however, the combination showed to be most effective and essentially stopped accumulation of leukemic cells in PB (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_972"><span data-history="original" data-attr-rid="F6">Figure 6H</span></cite>) and spleen (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_973"><span data-history="original" data-attr-rid="F6">Figure 6I</span></cite>). Interestingly, follow-up analysis after treatment cessation showed rapid progression of ibrutinib-treated animals; this ibrutinib effect was significantly slowed down by PF-670462 cotreatment (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_974"><span data-history="original" data-attr-rid="F6">Figure 6J</span></cite>). PF-670462<span data-html-name="unicode-char">–</span>only treated mice survived the longest (<cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_975"><span data-history="original" data-attr-rid="F6">Figure 6J</span></cite>), which shows that PF-670462 brings significant benefits both as a single agent and in combination with ibrutinib. In summary, these results demonstrate that CK1 inhibition represents a viable treatment strategy that can be efficiently combined with BCR inhibitors.<span data-html-name="display-formula" data-name="OPT_ID_976" data-attr-id="eq5" data-para="true"><span data-html-name="math" data-current-version="1" data-standard-html-version="1.0" data-math-mode="graphical-noneditable" data-name="OPT_ID_978" data-math-type="display-numbered"><span data-version="1"><span data-type="gp-image" data-attr-xlink-href="blood786947eq5" data-name="OPT_ID_978" data-original-web-src="https://pgc-dev-test.s3.amazonaws.com/13398/proofs/sjs/BLOOD/786947/1/images/blood786947eq5.svg" data-edit-view-url="https://pgc-dev-test.s3.amazonaws.com/13398/proofs/sjs/BLOOD/786947/1/images/blood786947eq5.svg"></span></span></span><span data-html-name="math-label" data-name="OPT_ID_977" data-para="true">[5]</span></span></div></section></section><section data-html-name="section" data-name="OPT_ID_979" data-attr-sec-type="discussion" data-para="true"><h2 data-html-name="section-title" aria-level="2" data-name="OPT_ID_980" data-para="true">Discussion</h2><div data-html-name="para" data-name="OPT_ID_981" data-para="true">In the present study, we provide evidence that CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibition can slow down development of CLL in E<span data-html-name="unicode-char">µ</span>-TCL1 transgenic mice (AT and spontaneous disease development) and that the CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibitor PF-670462 can improve overall survival in this mouse model. Even though there are numerous links of CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> isoforms to cancer development,<span data-format="superscript" data-actor="org" data-name="OPT_ID_982"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_983"><span data-history="original" data-attr-rid="B47 B48 B49 B50 B51">47-51</span></cite></span> only a limited number of studies describing CK1 inhibition as an option for cancer therapy exist; the published studies use mostly IC261 compound to block cancer cell proliferation,<span data-format="superscript" data-actor="org" data-name="OPT_ID_984"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_985"><span data-history="original" data-attr-rid="B52 B53 B54 B55">52-55</span></cite></span> an effect that is likely to be observed because of the off-target effects of this inhibitor.<span data-format="superscript" data-actor="org" data-name="OPT_ID_986"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_987"><span data-history="original" data-attr-rid="B56">56</span></cite></span> Our study is thus the first one that shows the potential of specific CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibition in cancer treatment using a spontaneous disease in vivo model and demonstrates its therapeutic effects at doses that do not cause any apparent toxicity.</div><div data-html-name="para" data-name="OPT_ID_988" data-para="true">Our study further expands the earlier observations that CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibitors can block chemotaxis and transendothelial migration of primary CLL cells in vitro<span data-format="superscript" data-actor="org" data-name="OPT_ID_989"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_990"><span data-history="original" data-attr-rid="B7 B8">7,8</span></cite></span> and disrupt CLL cell homing to lymphoid organs in vivo.<span data-format="superscript" data-actor="org" data-name="OPT_ID_991"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_992"><span data-history="original" data-attr-rid="B7">7</span></cite></span> We show that CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibition blocks production of CCL3 and CCL4 by CLL cells and also blocks CLL migration in response to multiple microenvironmental stimuli. These diverse activities possibly converge on the requirement of CK1 activity for establishment of cell polarity and asymmetric localization of Wnt/PCP components, namely VANGL2, as was shown earlier using live imaging in MEC-1 cells.<span data-format="superscript" data-actor="org" data-name="OPT_ID_993"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_994"><span data-history="original" data-attr-rid="B8">8</span></cite></span> Our data not only highlight the importance of CK1-controlled processes in CLL pathogenesis, but also identify CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibitors as candidate drugs for CLL. So far, only anti-ROR1 antibodies have been studied in this context, and especially UC-961<span data-format="superscript" data-actor="org" data-name="OPT_ID_995"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_996"><span data-history="original" data-attr-rid="B57 B58">57,58</span></cite></span> showed highly promising effects. The effects of ROR1 inhibition were further described by others and carry high potential in the clinical applications in CLL as well as other ROR1-driven malignancies.<span data-format="superscript" data-actor="org" data-name="OPT_ID_997"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_998"><span data-history="original" data-attr-rid="B11 B12 B57 B59 B60 B61 B62">11,12,57,59-62</span></cite></span> CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibition represents a complementary, small-molecule<span data-html-name="unicode-char">–</span>based approach to anti-ROR1 antibodies and further widens the treatment options based on targeting of Wnt/PCP signaling.</div><div data-html-name="para" data-name="OPT_ID_999" data-para="true">Despite the undeniable benefits of recently approved compounds, mainly the BCR inhibitors ibrutinib and idelalisib<span data-format="superscript" data-actor="org" data-name="OPT_ID_1000"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_1001"><span data-history="original" data-attr-rid="B63">63</span></cite></span> and Bcl2 inhibitor venetoclax,<span data-format="superscript" data-actor="org" data-name="OPT_ID_1002"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_1003"><span data-history="original" data-attr-rid="B64">64</span></cite></span> the clinical trials have identified multiple side effects of these inhibitors<span data-format="superscript" data-actor="org" data-name="OPT_ID_1004"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_1005"><span data-history="original" data-attr-rid="B64 B65">64,65</span></cite></span> and a risk of acquired resistance in the case of BTK inhibitors.<span data-format="superscript" data-actor="org" data-name="OPT_ID_1006"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_1007"><span data-history="original" data-attr-rid="B66">66</span></cite></span> In addition, the treatments are not curative and need to be ideally indefinite. All these facts argue for further exploitation of the novel therapeutic targets. This involves validation of the therapeutic potential of CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibitors, which were so far tested and well tolerated in preclinical in vivo studies.<span data-format="superscript" data-actor="org" data-name="OPT_ID_1008"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_1009"><span data-history="original" data-attr-rid="B27 B28 B33 B34 B67">27,28,33,34,67</span></cite></span> Interestingly, CK1<span data-html-name="unicode-char">ε</span> was shown to be targeted by a PI3K<span data-html-name="unicode-char">δ</span> inhibitor TGR-1202 (umbralisib),<span data-format="superscript" data-actor="org" data-name="OPT_ID_1010"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_1011"><span data-history="original" data-attr-rid="B68">68</span></cite></span> currently in phase 3 clinical trial, which shows good activity and differs from the other PI3K<span data-html-name="unicode-char">δ</span> inhibitors by a better safety profile.<span data-format="superscript" data-actor="org" data-name="OPT_ID_1012"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_1013"><span data-history="original" data-attr-rid="B69 B70">69,70</span></cite></span> It must be further explored in future whether this is because of the dual PI3K<span data-html-name="unicode-char">δ</span> and CK1<span data-html-name="unicode-char">ε</span> activity of TGR-1202.</div><div data-html-name="para" data-name="OPT_ID_1014" data-para="true">To verify the beneficial effects of CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> inhibition in a combination therapy, a strategy commonly applied in CLL,<span data-format="superscript" data-actor="org" data-name="OPT_ID_1015"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_1016"><span data-history="original" data-attr-rid="B71">71</span></cite></span> we have explored the effects of a combined treatment by CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> and BTK inhibitors. This combination showed to be synergistic in vitro and beneficial also in vivo. PF-670462 slowed down the rapid disease progression after ibrutinib withdrawal that appeared in line with the fact that ibrutinib cannot completely eradicate the disease in mice<span data-format="superscript" data-actor="org" data-name="OPT_ID_1017"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_1018"><span data-history="original" data-attr-rid="B36 B46">36,46</span></cite></span> and CLL patients.<span data-format="superscript" data-actor="org" data-name="OPT_ID_1019"><cite data-standard-html-version="1.0" data-html-name="bib" data-attr-ref-type="bibr" data-name="OPT_ID_1020"><span data-history="original" data-attr-rid="B72">72</span></cite></span> Even though we could not cure the disease in the mouse model completely using the current experimental setup, we hypothesize that a careful optimization of the conditions used (eg, differences in a solvent, water vs kolliphor; compare <cite data-standard-html-version="1.0" data-html-name="fig" data-attr-ref-type="fig" data-name="OPT_ID_1021"><span data-history="original" data-attr-rid="F4 F6">Figures 4H and 6J</span></cite>) and better understanding of the compound pharmacokinetics may deliver even stronger effects. This, together with testing of further treatment combinations, is, however, out of the scope of the current study.</div><div data-html-name="para" data-name="OPT_ID_1022" data-para="true">In summary, we have identified inhibition of CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> as a novel approach for interference with the network of microenvironment-controlled pathways. Overall, the evidence presented in this manuscript demonstrates that CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> should be considered as a valid therapeutic target in CLL and potentially also in other CK1-driven malignancies.</div></section><section data-html-name="acknowledgment" data-name="OPT_ID_1029" data-para="true"><h2 data-html-name="section-title" aria-level="2" data-name="OPT_ID_1030" data-para="true">Acknowledgments</h2><div data-html-name="para" data-name="OPT_ID_1031" data-para="true">The authors thank the staff of the Department of Internal Medicine<span data-html-name="unicode-char">–</span>Hematology and Oncology, University Hospital Brno for the help with collecting biological samples from CLL patients, and Carlo Croce (The Ohio State University College of Medicine) for providing us with the E<span data-html-name="unicode-char">µ</span>-TCL1 mice.</div><div data-html-name="para" data-name="OPT_ID_1032" data-para="true">This work was supported by grants from the Ministry of Health of the Czech Republic (15-29793A, 16-34152A); Masaryk University/Internal projects of TTO (MUNI/31/53609/2016); the Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC 2020 (LQ1601); the Ministry of Health, Czech Republic<span data-html-name="unicode-char">–</span>Conceptual Development of Research Organization (FNBr, 65269705); the European Commission (WntsApp Marie Curie Initial Training Network); the Ministry of Agriculture Institutional (grant RO0517); and the Czech Science Foundation (grant 16-24043J). A.E.<span data-html-name="unicode-char">’</span>s work on CLL is supported by FWF grants p26719 and I1299 (FOR2036). P.J.<span data-html-name="unicode-char">’</span>s work on the manuscript was supported by Masaryk University Grant Agency project MUNI/E/0102/2017.</div></section><section data-html-name="section" data-name="OPT_ID_1033" data-para="true"><h2 data-html-name="section-title" aria-level="2" data-name="OPT_ID_1034" data-para="true">Authorship</h2><div data-html-name="para" data-name="OPT_ID_1035" data-para="true">Contribution: V.B., P.J., J.V., J.K., and T.N. were responsible for experimental design and data analysis; P.J., V.B., and J.V. wrote the manuscript; J.V., J.K., M.D., H.S., T.N., and P.J. worked with the animals; T.R., L.B., T.N., P.J., L.S., M.G., and O.V.B. performed in vitro experiments/analysis of samples from mice; K.V., J.V., and Z.H. performed ultrasound and other special analysis; P.O. performed statistical analysis; A.E., S. Pavlova, K.P., and L.P. provided crucial material and know-how; and V.B. and S. Pospisilova supervised the study.</div><div data-html-name="para" data-name="OPT_ID_1036" data-para="true">Conflict-of-interest disclosure: V.B., S. Pavlova, K.P., and S. Pospisilova are listed as inventors in the patent application <span data-html-name="unicode-char">“</span>WO 2014023271 A1: Casein kinase 1 inhibitors for the treatment of b-cell chronic lymphocytic leukemia.<span data-html-name="unicode-char">”</span></div></section><div data-html-name="footnote-group" data-standard-html-version="1.0" data-name="OPT_ID_1024" data-para="true"><div data-html-name="text-fn" data-name="OPT_ID_1025" data-attr-fn-type="supplementary-material" data-para="true"><span data-html-name="para" data-name="OPT_ID_1026" data-para="true">The online version of this article contains a data supplement.</span><span data-html-name="fn-label"></span></div><div data-html-name="text-fn" data-name="OPT_ID_1027" data-attr-fn-type="financial-disclosure" data-para="true"><span data-html-name="para" data-name="OPT_ID_1028" data-para="true">The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked <span data-html-name="unicode-char">“</span>advertisement<span data-html-name="unicode-char">”</span> in accordance with 18 USC section 1734.</span><span data-html-name="fn-label"></span></div><div data-html-name="footnote-group-title"></div></div><section data-html-name="back-matter"><div data-html-name="bibliography" data-standard-html-version="1.0" data-name="OPT_ID_1039" data-para="true" data-meta-info="reference:mixed-citation author:string-name editor:string-name"><h1 data-html-name="bibliography-heading" data-name="OPT_ID_1040" aria-level="2" data-para="true">References</h1><div data-html-name="bibliography-section-wrapper"><h2 data-html-name="bibliography-section-title" data-auto-generated="true"></h2><ul data-html-name="bibliography-section" data-reference-type="numbered"><li data-html-name="bibliography-reference" data-name="OPT_ID_1041" data-attr-id="B1" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1042">1.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1043" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1044" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1045"><span data-html-name="surname" data-name="OPT_ID_1046">Crassini</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1047">K</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1048"><span data-html-name="surname" data-name="OPT_ID_1049">Mulligan</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1050">SP</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1051"><span data-html-name="surname" data-name="OPT_ID_1052">Best</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1053">OG</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="collaboration"></span><span data-html-name="etal"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1054">Targeting chronic lymphocytic leukemia cells in the tumor microenvironment: a review of the in vitro and clinical trials to date</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1055">World J Clin Cases</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1056">2015</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1057">3</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1058">8</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1059">694</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1060">704</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1061" data-attr-id="B2" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1062">2.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1063" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1064" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1065"><span data-html-name="surname" data-name="OPT_ID_1066">Galletti</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1067">G</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1068"><span data-html-name="surname" data-name="OPT_ID_1069">Scielzo</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1070">C</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1071"><span data-html-name="surname" data-name="OPT_ID_1072">Barbaglio</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1073">F</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1074">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1075">Targeting macrophages sensitizes chronic lymphocytic leukemia to apoptosis and inhibits disease progression</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1076">Cell Reports</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1077">2016</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1078">14</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1079">7</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1080">1748</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1081">1760</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1082" data-attr-id="B3" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1083">3.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1084" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1085" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1086"><span data-html-name="surname" data-name="OPT_ID_1087">Packham</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1088">G</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1089"><span data-html-name="surname" data-name="OPT_ID_1090">Krysov</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1091">S</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1092"><span data-html-name="surname" data-name="OPT_ID_1093">Allen</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1094">A</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1095">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1096">The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1097">Haematologica</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1098">2014</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1099">99</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1100">7</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1101">1138</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1102">1148</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1103" data-attr-id="B4" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1104">4.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1105" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1106" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1107"><span data-html-name="surname" data-name="OPT_ID_1108">Baskar</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1109">S</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1110"><span data-html-name="surname" data-name="OPT_ID_1111">Kwong</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1112">KY</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1113"><span data-html-name="surname" data-name="OPT_ID_1114">Hofer</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1115">T</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1116">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1117">Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1118">Clin Cancer Res</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1119">2008</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1120">14</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1121">2</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1122">396</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1123">404</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1124" data-attr-id="B5" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1125">5.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1126" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1127" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1128"><span data-html-name="surname" data-name="OPT_ID_1129">Fukuda</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1130">T</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1131"><span data-html-name="surname" data-name="OPT_ID_1132">Chen</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1133">L</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1134"><span data-html-name="surname" data-name="OPT_ID_1135">Endo</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1136">T</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1137">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1138">Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1139">Proc Natl Acad Sci USA</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1140">2008</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1141">105</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1142">8</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1143">3047</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1144">3052</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1145" data-attr-id="B6" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1146">6.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1147" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1148" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1149"><span data-html-name="surname" data-name="OPT_ID_1150">DaneshManesh</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1151">AH</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1152"><span data-html-name="surname" data-name="OPT_ID_1153">Mikaelsson</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1154">E</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1155"><span data-html-name="surname" data-name="OPT_ID_1156">Jeddi-Tehrani</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1157">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1158">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1159">Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1160">Int J Cancer</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1161">2008</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1162">123</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1163">5</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1164">1190</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1165">1195</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1166" data-attr-id="B7" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1167">7.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1168" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1169" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1170"><span data-html-name="surname" data-name="OPT_ID_1171">Kauck<span data-html-name="unicode-char">á</span></span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1172">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1173"><span data-html-name="surname" data-name="OPT_ID_1174">Plevov<span data-html-name="unicode-char">á</span></span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1175">K</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1176"><span data-html-name="surname" data-name="OPT_ID_1177">Pavlov<span data-html-name="unicode-char">á</span></span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1178">S</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1179">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1180">The planar cell polarity pathway drives pathogenesis of chronic lymphocytic leukemia by the regulation of B-lymphocyte migration</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1181">Cancer Res</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1182">2013</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1183">73</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1184">5</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1185">1491</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1186">1501</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1187" data-attr-id="B8" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1188">8.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1189" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1190" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1191"><span data-html-name="surname" data-name="OPT_ID_1192">Kauck<span data-html-name="unicode-char">á</span></span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1193">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1194"><span data-html-name="surname" data-name="OPT_ID_1195">Petersen</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1196">J</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1197"><span data-html-name="surname" data-name="OPT_ID_1198">Janovsk<span data-html-name="unicode-char">á</span></span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1199">P</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1200">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1201">Asymmetry of VANGL2 in migrating lymphocytes as a tool to monitor activity of the mammalian WNT/planar cell polarity pathway</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1202">Cell Commun Signal</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1203">2015</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1204">13</span><span data-html-name="unknown">:</span><span data-html-name="first-page" data-name="OPT_ID_1205">2</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="issue-nr"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="last-page"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1206" data-attr-id="B9" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1207">9.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1208" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1209" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1210"><span data-html-name="surname" data-name="OPT_ID_1211">Khan</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1212">AS</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1213"><span data-html-name="surname" data-name="OPT_ID_1214">Hojjat-Farsangi</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1215">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1216"><span data-html-name="surname" data-name="OPT_ID_1217">Daneshmanesh</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1218">AH</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1219">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1220">Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1221">Tumour Biol</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1222">2016</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1223">37</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1224">9</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1225">11947</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1226">11957</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1227" data-attr-id="B10" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1228">10.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1229" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1230" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1231"><span data-html-name="surname" data-name="OPT_ID_1232">Janovska</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1233">P</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1234"><span data-html-name="surname" data-name="OPT_ID_1235">Poppova</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1236">L</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1237"><span data-html-name="surname" data-name="OPT_ID_1238">Plevova</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1239">K</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1240">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1241">Autocrine signaling by Wnt-5a deregulates chemotaxis of leukemic cells and predicts clinical outcome in chronic lymphocytic leukemia</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1242">Clin Cancer Res</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1243">2016</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1244">22</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1245">2</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1246">459</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1247">469</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1248" data-attr-id="B11" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1249">11.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1250" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1251" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1252"><span data-html-name="surname" data-name="OPT_ID_1253">Yu</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1254">J</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1255"><span data-html-name="surname" data-name="OPT_ID_1256">Chen</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1257">L</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1258"><span data-html-name="surname" data-name="OPT_ID_1259">Cui</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1260">B</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1261">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1262">Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1263">J Clin Invest</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1264">2016</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1265">126</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1266">2</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1267">585</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1268">598</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1269" data-attr-id="B12" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1270">12.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1271" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1272" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1273"><span data-html-name="surname" data-name="OPT_ID_1274">Widhopf</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1275">GF</span><span data-html-name="unknown"> </span><span data-html-name="suffix" data-name="OPT_ID_1276">II</span><span data-html-name="prefix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1277"><span data-html-name="surname" data-name="OPT_ID_1278">Cui</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1279">B</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1280"><span data-html-name="surname" data-name="OPT_ID_1281">Ghia</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1282">EM</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1283">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1284">ROR1 can interact with TCL1 and enhance leukemogenesis in E<span data-html-name="unicode-char">μ</span>-TCL1 transgenic mice</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1285">Proc Natl Acad Sci USA</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1286">2014</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1287">111</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1288">2</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1289">793</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1290">798</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1291" data-attr-id="B13" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1292">13.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1293" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1294" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1295"><span data-html-name="surname" data-name="OPT_ID_1296">Wu</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1297">QL</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1298"><span data-html-name="surname" data-name="OPT_ID_1299">Zierold</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1300">C</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1301"><span data-html-name="surname" data-name="OPT_ID_1302">Ranheim</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1303">EA</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="collaboration"></span><span data-html-name="etal"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1304">Dysregulation of Frizzled 6 is a critical component of B-cell leukemogenesis in a mouse model of chronic lymphocytic leukemia</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1305">Blood</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1306">2009</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1307">113</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1308">13</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1309">3031</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1310">3039</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1311" data-attr-id="B14" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1312">14.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1313" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1314" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1315"><span data-html-name="surname" data-name="OPT_ID_1316">Linke</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1317">F</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1318"><span data-html-name="surname" data-name="OPT_ID_1319">Zaunig</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1320">S</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1321"><span data-html-name="surname" data-name="OPT_ID_1322">Nietert</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1323">MM</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1324">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1325">WNT5A: a motility-promoting factor in Hodgkin lymphoma</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1326">Oncogene</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1327">2016</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1328">36</span><span data-html-name="unknown">:</span><span data-html-name="first-page" data-name="OPT_ID_1329">13</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1330">23</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="issue-nr"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1331" data-attr-id="B15" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1332">15.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1333" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1334" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1335"><span data-html-name="surname" data-name="OPT_ID_1336">Daneshmanesh</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1337">AH</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1338"><span data-html-name="surname" data-name="OPT_ID_1339">Porwit</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1340">A</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1341"><span data-html-name="surname" data-name="OPT_ID_1342">Hojjat-Farsangi</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1343">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1344">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1345">Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1346">Leuk Lymphoma</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1347">2013</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1348">54</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1349">4</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1350">843</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1351">850</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1352" data-attr-id="B16" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1353">16.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1354" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1355" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1356"><span data-html-name="surname" data-name="OPT_ID_1357">Barna</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1358">G</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1359"><span data-html-name="surname" data-name="OPT_ID_1360">Mihalik</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1361">R</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1362"><span data-html-name="surname" data-name="OPT_ID_1363">Tim<span data-html-name="unicode-char">á</span>r</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1364">B</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1365">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1366">ROR1 expression is not a unique marker of CLL</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1367">Hematol Oncol</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1368">2011</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1369">29</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1370">1</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1371">17</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1372">21</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1373" data-attr-id="B17" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1374">17.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1375" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1376" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1377"><span data-html-name="surname" data-name="OPT_ID_1378">Janovsk<span data-html-name="unicode-char">á</span></span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1379">P</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1380"><span data-html-name="surname" data-name="OPT_ID_1381">Bryja</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1382">V</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="collaboration"></span><span data-html-name="etal"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1383">Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1384">Br J Pharmacol</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1385">2017</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1386">174</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1387">24</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1388">4701</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1389">4715</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1390" data-attr-id="B18" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1391">18.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1392" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1393" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1394"><span data-html-name="surname" data-name="OPT_ID_1395">Bryja</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1396">V</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1397"><span data-html-name="surname" data-name="OPT_ID_1398">Schulte</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1399">G</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1400"><span data-html-name="surname" data-name="OPT_ID_1401">Rawal</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1402">N</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1403"><span data-html-name="surname" data-name="OPT_ID_1404">Grahn</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1405">A</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1406"><span data-html-name="surname" data-name="OPT_ID_1407">Arenas</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1408">E</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="collaboration"></span><span data-html-name="etal"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1409">Wnt-5a induces Dishevelled phosphorylation and dopaminergic differentiation via a CK1-dependent mechanism</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1410">J Cell Sci</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1411">2007</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1412">120</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1413">4</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1414">586</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1415">595</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1416" data-attr-id="B19" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1417">19.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1418" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1419" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1420"><span data-html-name="surname" data-name="OPT_ID_1421">Hallek</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1422">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1423"><span data-html-name="surname" data-name="OPT_ID_1424">Cheson</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1425">BD</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1426"><span data-html-name="surname" data-name="OPT_ID_1427">Catovsky</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1428">D</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1429">et al.</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">; </span><span data-html-name="collaboration" data-name="OPT_ID_1430">International Workshop on Chronic Lymphocytic Leukemia</span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1431">Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1432">Blood</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1433">2008</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1434">111</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1435">12</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1436">5446</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1437">5456</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1438" data-attr-id="B20" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1439">20.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1440" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1441" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1442"><span data-html-name="surname" data-name="OPT_ID_1443">Stacchini</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1444">A</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1445"><span data-html-name="surname" data-name="OPT_ID_1446">Aragno</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1447">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1448"><span data-html-name="surname" data-name="OPT_ID_1449">Vallario</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1450">A</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1451">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1452">MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1453">Leuk Res</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1454">1999</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1455">23</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1456">2</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1457">127</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1458">136</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1459" data-attr-id="B21" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1460">21.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1461" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1462" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1463"><span data-html-name="surname" data-name="OPT_ID_1464">Kurtova</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1465">AV</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1466"><span data-html-name="surname" data-name="OPT_ID_1467">Balakrishnan</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1468">K</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1469"><span data-html-name="surname" data-name="OPT_ID_1470">Chen</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1471">R</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1472">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1473">Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1474">Blood</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1475">2009</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1476">114</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1477">20</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1478">4441</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1479">4450</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1480" data-attr-id="B22" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1481">22.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1482" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1483" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1484"><span data-html-name="surname" data-name="OPT_ID_1485">Kilkenny</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1486">C</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1487"><span data-html-name="surname" data-name="OPT_ID_1488">Browne</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1489">WJ</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1490"><span data-html-name="surname" data-name="OPT_ID_1491">Cuthill</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1492">IC</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1493"><span data-html-name="surname" data-name="OPT_ID_1494">Emerson</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1495">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1496"><span data-html-name="surname" data-name="OPT_ID_1497">Altman</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1498">DG</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="collaboration"></span><span data-html-name="etal"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1499">Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1500">J Pharmacol Pharmacother</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1501">2010</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1502">1</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1503">2</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1504">94</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1505">99</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1506" data-attr-id="B23" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1507">23.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1508" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1509" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1510"><span data-html-name="surname" data-name="OPT_ID_1511">Bichi</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1512">R</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1513"><span data-html-name="surname" data-name="OPT_ID_1514">Shinton</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1515">SA</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1516"><span data-html-name="surname" data-name="OPT_ID_1517">Martin</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1518">ES</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1519">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1520">Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1521">Proc Natl Acad Sci USA</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1522">2002</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1523">99</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1524">10</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1525">6955</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1526">6960</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1527" data-attr-id="B24" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1528">24.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1529" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1530" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1531"><span data-html-name="surname" data-name="OPT_ID_1532">Rhodes</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1533">DR</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1534"><span data-html-name="surname" data-name="OPT_ID_1535">Yu</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1536">J</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1537"><span data-html-name="surname" data-name="OPT_ID_1538">Shanker</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1539">K</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1540">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1541">ONCOMINE: a cancer microarray database and integrated data-mining platform</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1542">Neoplasia</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1543">2004</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1544">6</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1545">1</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1546">1</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1547">6</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1548" data-attr-id="B25" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1549">25.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1550" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1551" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1552"><span data-html-name="surname" data-name="OPT_ID_1553">Basso</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1554">K</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1555"><span data-html-name="surname" data-name="OPT_ID_1556">Margolin</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1557">AA</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1558"><span data-html-name="surname" data-name="OPT_ID_1559">Stolovitzky</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1560">G</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1561"><span data-html-name="surname" data-name="OPT_ID_1562">Klein</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1563">U</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1564"><span data-html-name="surname" data-name="OPT_ID_1565">Dalla-Favera</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1566">R</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1567"><span data-html-name="surname" data-name="OPT_ID_1568">Califano</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1569">A</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="collaboration"></span><span data-html-name="etal"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1570">Reverse engineering of regulatory networks in human B cells</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1571">Nat Genet</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1572">2005</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1573">37</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1574">4</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1575">382</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1576">390</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1577" data-attr-id="B26" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1578">26.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1579" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1580" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1581"><span data-html-name="surname" data-name="OPT_ID_1582">Haferlach</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1583">T</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1584"><span data-html-name="surname" data-name="OPT_ID_1585">Kohlmann</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1586">A</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1587"><span data-html-name="surname" data-name="OPT_ID_1588">Wieczorek</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1589">L</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1590">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1591">Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1592">J Clin Oncol</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1593">2010</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1594">28</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1595">15</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1596">2529</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1597">2537</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1598" data-attr-id="B27" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1599">27.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1600" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1601" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1602"><span data-html-name="surname" data-name="OPT_ID_1603">Walton</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1604">KM</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1605"><span data-html-name="surname" data-name="OPT_ID_1606">Fisher</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1607">K</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1608"><span data-html-name="surname" data-name="OPT_ID_1609">Rubitski</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1610">D</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1611">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1612">Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock period</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1613">J Pharmacol Exp Ther</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1614">2009</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1615">330</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1616">2</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1617">430</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1618">439</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1619" data-attr-id="B28" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1620">28.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1621" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1622" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1623"><span data-html-name="surname" data-name="OPT_ID_1624">Badura</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1625">L</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1626"><span data-html-name="surname" data-name="OPT_ID_1627">Swanson</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1628">T</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1629"><span data-html-name="surname" data-name="OPT_ID_1630">Adamowicz</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1631">W</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1632">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1633">An inhibitor of casein kinase I epsilon induces phase delays in circadian rhythms under free-running and entrained conditions</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1634">J Pharmacol Exp Ther</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1635">2007</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1636">322</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1637">2</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1638">730</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1639">738</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1640" data-attr-id="B29" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1641">29.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1642" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1643" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1644"><span data-html-name="surname" data-name="OPT_ID_1645">Rena</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1646">G</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1647"><span data-html-name="surname" data-name="OPT_ID_1648">Bain</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1649">J</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1650"><span data-html-name="surname" data-name="OPT_ID_1651">Elliott</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1652">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1653"><span data-html-name="surname" data-name="OPT_ID_1654">Cohen</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1655">P</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="collaboration"></span><span data-html-name="etal"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1656">D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1657">EMBO Rep</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1658">2004</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1659">5</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1660">1</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1661">60</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1662">65</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1663" data-attr-id="B30" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1664">30.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1665" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1666" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1667"><span data-html-name="surname" data-name="OPT_ID_1668">Chan</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1669">PY</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1670"><span data-html-name="surname" data-name="OPT_ID_1671">Aruffo</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1672">A</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="collaboration"></span><span data-html-name="etal"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1673">VLA-4 integrin mediates lymphocyte migration on the inducible endothelial cell ligand VCAM-1 and the extracellular matrix ligand fibronectin</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1674">J Biol Chem</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1675">1993</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1676">268</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1677">33</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1678">24655</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1679">24664</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1680" data-attr-id="B31" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1681">31.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1682" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1683" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1684"><span data-html-name="surname" data-name="OPT_ID_1685">Burger</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1686">JA</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1687"><span data-html-name="surname" data-name="OPT_ID_1688">Quiroga</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1689">MP</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1690"><span data-html-name="surname" data-name="OPT_ID_1691">Hartmann</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1692">E</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1693">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1694">High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1695">Blood</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1696">2009</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1697">113</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1698">13</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1699">3050</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1700">3058</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1701" data-attr-id="B32" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1702">32.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1703" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1704" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1705"><span data-html-name="surname" data-name="OPT_ID_1706">Hartmann</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1707">EM</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1708"><span data-html-name="surname" data-name="OPT_ID_1709">Rudelius</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1710">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1711"><span data-html-name="surname" data-name="OPT_ID_1712">Burger</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1713">JA</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1714"><span data-html-name="surname" data-name="OPT_ID_1715">Rosenwald</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1716">A</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="collaboration"></span><span data-html-name="etal"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1717">CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltrates</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1718">Leuk Lymphoma</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1719">2016</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1720">57</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1721">3</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1722">563</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1723">571</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1724" data-attr-id="B33" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1725">33.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1726" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1727" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1728"><span data-html-name="surname" data-name="OPT_ID_1729">Sprouse</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1730">J</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1731"><span data-html-name="surname" data-name="OPT_ID_1732">Reynolds</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1733">L</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1734"><span data-html-name="surname" data-name="OPT_ID_1735">Swanson</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1736">TA</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1737"><span data-html-name="surname" data-name="OPT_ID_1738">Engwall</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1739">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="collaboration"></span><span data-html-name="etal"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1740">Inhibition of casein kinase I epsilon/delta produces phase shifts in the circadian rhythms of cynomolgus monkeys</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1741">Psychopharmacology (Berl)</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1742">2009</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1743">204</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1744">4</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1745">735</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1746">742</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1747" data-attr-id="B34" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1748">34.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1749" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1750" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1751"><span data-html-name="surname" data-name="OPT_ID_1752">Perreau-Lenz</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1753">S</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1754"><span data-html-name="surname" data-name="OPT_ID_1755">Vengeliene</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1756">V</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1757"><span data-html-name="surname" data-name="OPT_ID_1758">Noori</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1759">HR</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1760">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1761">Inhibition of the casein-kinase-1-<span data-html-name="unicode-char">ε</span>/<span data-html-name="unicode-char">δ</span>/ prevents relapse-like alcohol drinking</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1762">Neuropsychopharmacology</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1763">2012</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1764">37</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1765">9</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1766">2121</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1767">2131</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1768" data-attr-id="B35" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1769">35.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1770" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1771" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1772"><span data-html-name="surname" data-name="OPT_ID_1773">Suljagic</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1774">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1775"><span data-html-name="surname" data-name="OPT_ID_1776">Longo</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1777">PG</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1778"><span data-html-name="surname" data-name="OPT_ID_1779">Bennardo</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1780">S</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1781">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1782">The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the E<span data-html-name="unicode-char">μ</span>- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1783">Blood</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1784">2010</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1785">116</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1786">23</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1787">4894</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1788">4905</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1789" data-attr-id="B36" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1790">36.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1791" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1792" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1793"><span data-html-name="surname" data-name="OPT_ID_1794">Ponader</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1795">S</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1796"><span data-html-name="surname" data-name="OPT_ID_1797">Chen</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1798">SS</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1799"><span data-html-name="surname" data-name="OPT_ID_1800">Buggy</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1801">JJ</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1802">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1803">The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1804">Blood</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1805">2012</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1806">119</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1807">5</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1808">1182</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1809">1189</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1810" data-attr-id="B37" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1811">37.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1812" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1813" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1814"><span data-html-name="surname" data-name="OPT_ID_1815">Blunt</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1816">MD</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1817"><span data-html-name="surname" data-name="OPT_ID_1818">Carter</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1819">MJ</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1820"><span data-html-name="surname" data-name="OPT_ID_1821">Larrayoz</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1822">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1823">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1824">The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the E<span data-html-name="unicode-char">µ</span>-TCL1 mouse model</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1825">Blood</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1826">2015</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1827">125</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1828">26</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1829">4032</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1830">4041</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1831" data-attr-id="B38" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1832">38.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1833" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1834" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1835"><span data-html-name="surname" data-name="OPT_ID_1836">Edgar</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1837">R</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1838"><span data-html-name="surname" data-name="OPT_ID_1839">Domrachev</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1840">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1841"><span data-html-name="surname" data-name="OPT_ID_1842">Lash</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1843">AE</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="collaboration"></span><span data-html-name="etal"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1844">Gene Expression Omnibus: NCBI gene expression and hybridization array data repository</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1845">Nucleic Acids Res</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1846">2002</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1847">30</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1848">1</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1849">207</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1850">210</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1851" data-attr-id="B39" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1852">39.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1853" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1854" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1855"><span data-html-name="surname" data-name="OPT_ID_1856">Barrett</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1857">T</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1858"><span data-html-name="surname" data-name="OPT_ID_1859">Wilhite</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1860">SE</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1861"><span data-html-name="surname" data-name="OPT_ID_1862">Ledoux</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1863">P</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1864">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1865">NCBI GEO: archive for functional genomics data sets--update</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1866">Nucleic Acids Res</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1867">2013</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1868">41</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1869">Database issue</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1870">D991</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1871">D995</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1872" data-attr-id="B40" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1873">40.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1874" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1875" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1876"><span data-html-name="surname" data-name="OPT_ID_1877">Heinig</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1878">K</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1879"><span data-html-name="surname" data-name="OPT_ID_1880">G<span data-html-name="unicode-char">ä</span>tjen</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1881">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1882"><span data-html-name="surname" data-name="OPT_ID_1883">Grau</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1884">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1885">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1886">Access to follicular dendritic cells is a pivotal step in murine chronic lymphocytic leukemia B-cell activation and proliferation</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1887">Cancer Discov</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1888">2014</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1889">4</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1890">12</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1891">1448</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1892">1465</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1893" data-attr-id="B41" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1894">41.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1895" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1896" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1897"><span data-html-name="surname" data-name="OPT_ID_1898">Bresin</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1899">A</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1900"><span data-html-name="surname" data-name="OPT_ID_1901">D<span data-html-name="unicode-char">’</span>Abundo</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1902">L</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1903"><span data-html-name="surname" data-name="OPT_ID_1904">Narducci</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1905">MG</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1906">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1907">TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1908">Cell Death Dis</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1909">2016</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1910">7</span><span data-html-name="unknown">:</span><span data-html-name="first-page" data-name="OPT_ID_1911">e2071</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="issue-nr"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="last-page"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1912" data-attr-id="B42" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1913">42.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1914" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1915" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1916"><span data-html-name="surname" data-name="OPT_ID_1917">Wiestner</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1918">A</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="collaboration"></span><span data-html-name="etal"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1919">BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1920">Hematology (Am Soc Hematol Educ Program)</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1921">2014</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1922">2014</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1923">1</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1924">125</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1925">134</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1926" data-attr-id="B43" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1927">43.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1928" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1929" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1930"><span data-html-name="surname" data-name="OPT_ID_1931">Yu</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1932">J</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1933"><span data-html-name="surname" data-name="OPT_ID_1934">Chen</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1935">L</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1936"><span data-html-name="surname" data-name="OPT_ID_1937">Cui</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1938">B</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1939">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1940">Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1941">Leukemia</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1942">2017</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1943">31</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1944">6</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1945">1333</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1946">1339</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1947" data-attr-id="B44" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1948">44.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1949" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1950" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1951"><span data-html-name="surname" data-name="OPT_ID_1952">Hasan</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1953">MK</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1954"><span data-html-name="surname" data-name="OPT_ID_1955">Yu</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1956">J</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1957"><span data-html-name="surname" data-name="OPT_ID_1958">Chen</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1959">L</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1960">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1961">Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1962">Leukemia</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1963">2017</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1964">31</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1965">12</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1966">2615</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1967">2622</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1968" data-attr-id="B45" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1969">45.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1970" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1971" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1972"><span data-html-name="surname" data-name="OPT_ID_1973">Chen</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1974">SS</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1975"><span data-html-name="surname" data-name="OPT_ID_1976">Chang</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1977">BY</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1978"><span data-html-name="surname" data-name="OPT_ID_1979">Chang</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1980">S</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_1981">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_1982">BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_1983">Leukemia</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_1984">2016</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_1985">30</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_1986">4</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_1987">833</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_1988">843</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_1989" data-attr-id="B46" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_1990">46.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_1991" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_1992" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_1993"><span data-html-name="surname" data-name="OPT_ID_1994">Woyach</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1995">JA</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1996"><span data-html-name="surname" data-name="OPT_ID_1997">Bojnik</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_1998">E</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_1999"><span data-html-name="surname" data-name="OPT_ID_2000">Ruppert</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2001">AS</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2002">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2003">Bruton<span data-html-name="unicode-char">’</span>s tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL)</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2004">Blood</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2005">2014</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2006">123</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2007">8</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2008">1207</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_2009">1213</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2010" data-attr-id="B47" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2011">47.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2012" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2013" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2014"><span data-html-name="surname" data-name="OPT_ID_2015">Knippschild</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2016">U</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2017"><span data-html-name="surname" data-name="OPT_ID_2018">Kr<span data-html-name="unicode-char">ü</span>ger</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2019">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2020"><span data-html-name="surname" data-name="OPT_ID_2021">Richter</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2022">J</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2023">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2024">The CK1 family: contribution to cellular stress response and its role in carcinogenesis</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2025">Front Oncol</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2026">2014</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2027">4</span><span data-html-name="unknown">:</span><span data-html-name="first-page" data-name="OPT_ID_2028">96</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="issue-nr"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="last-page"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2029" data-attr-id="B48" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2030">48.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2031" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2032" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2033"><span data-html-name="surname" data-name="OPT_ID_2034">Hirner</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2035">H</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2036"><span data-html-name="surname" data-name="OPT_ID_2037">G<span data-html-name="unicode-char">ü</span>nes</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2038">C</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2039"><span data-html-name="surname" data-name="OPT_ID_2040">Bischof</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2041">J</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2042">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2043">Impaired CK1 delta activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2044">PLoS One</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2045">2012</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2046">7</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2047">1</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2048">e29709</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="last-page"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2049" data-attr-id="B49" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2050">49.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2051" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2052" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2053"><span data-html-name="surname" data-name="OPT_ID_2054">Foldynov<span data-html-name="unicode-char">á</span>-Trant<span data-html-name="unicode-char">í</span>rkov<span data-html-name="unicode-char">á</span></span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2055">S</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2056"><span data-html-name="surname" data-name="OPT_ID_2057">Sekyrov<span data-html-name="unicode-char">á</span></span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2058">P</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2059"><span data-html-name="surname" data-name="OPT_ID_2060">Tmejov<span data-html-name="unicode-char">á</span></span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2061">K</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2062">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2063">Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2064">Breast Cancer Res</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2065">2010</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2066">12</span><span data-html-name="unknown">:</span><span data-html-name="first-page" data-name="OPT_ID_2067">R30</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="issue-nr"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="last-page"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2068" data-attr-id="B50" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2069">50.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2070" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2071" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2072"><span data-html-name="surname" data-name="OPT_ID_2073">Lin</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2074">SH</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2075"><span data-html-name="surname" data-name="OPT_ID_2076">Lin</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2077">YM</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2078"><span data-html-name="surname" data-name="OPT_ID_2079">Yeh</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2080">CM</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2081">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2082">Casein kinase 1 epsilon expression predicts poorer prognosis in low T-stage oral cancer patients</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2083">Int J Mol Sci</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2084">2014</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2085">15</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2086">2</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2087">2876</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_2088">2891</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2089" data-attr-id="B51" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2090">51.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2091" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2092" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2093"><span data-html-name="surname" data-name="OPT_ID_2094">Tsai</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2095">IC</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2096"><span data-html-name="surname" data-name="OPT_ID_2097">Woolf</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2098">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2099"><span data-html-name="surname" data-name="OPT_ID_2100">Neklason</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2101">DW</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2102">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2103">Disease-associated casein kinase I delta mutation may promote adenomatous polyps formation via a Wnt/beta-catenin independent mechanism</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2104">Int J Cancer</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2105">2007</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2106">120</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2107">5</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2108">1005</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_2109">1012</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2110" data-attr-id="B52" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2111">52.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2112" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2113" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2114"><span data-html-name="surname" data-name="OPT_ID_2115">Brockschmidt</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2116">C</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2117"><span data-html-name="surname" data-name="OPT_ID_2118">Hirner</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2119">H</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2120"><span data-html-name="surname" data-name="OPT_ID_2121">Huber</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2122">N</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2123">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2124">Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2125">Gut</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2126">2008</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2127">57</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2128">6</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2129">799</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_2130">806</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2131" data-attr-id="B53" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2132">53.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2133" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2134" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2135"><span data-html-name="surname" data-name="OPT_ID_2136">Yang</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2137">WS</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2138"><span data-html-name="surname" data-name="OPT_ID_2139">Stockwell</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2140">BR</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="collaboration"></span><span data-html-name="etal"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2141">Inhibition of casein kinase 1-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2142">Genome Biol</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2143">2008</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2144">9</span><span data-html-name="unknown">:</span><span data-html-name="first-page" data-name="OPT_ID_2145">R92</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="issue-nr"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="last-page"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2146" data-attr-id="B54" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2147">54.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2148" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2149" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2150"><span data-html-name="surname" data-name="OPT_ID_2151">Winkler</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2152">BS</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2153"><span data-html-name="surname" data-name="OPT_ID_2154">Oltmer</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2155">F</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2156"><span data-html-name="surname" data-name="OPT_ID_2157">Richter</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2158">J</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2159">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2160">CK1<span data-html-name="unicode-char">δ</span> in lymphoma: gene expression and mutation analyses and validation of CK1<span data-html-name="unicode-char">δ</span> kinase activity for therapeutic application</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2161">Front Cell Dev Biol</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2162">2015</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2163">3</span><span data-html-name="unknown">:</span><span data-html-name="first-page" data-name="OPT_ID_2164">9</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="issue-nr"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="last-page"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2165" data-attr-id="B55" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2166">55.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2167" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2168" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2169"><span data-html-name="surname" data-name="OPT_ID_2170">Rodriguez</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2171">N</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2172"><span data-html-name="surname" data-name="OPT_ID_2173">Yang</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2174">J</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2175"><span data-html-name="surname" data-name="OPT_ID_2176">Hasselblatt</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2177">K</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2178">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2179">Casein kinase I epsilon interacts with mitochondrial proteins for the growth and survival of human ovarian cancer cells</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2180">EMBO Mol Med</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2181">2012</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2182">4</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2183">9</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2184">952</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_2185">963</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2186" data-attr-id="B56" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2187">56.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2188" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2189" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2190"><span data-html-name="surname" data-name="OPT_ID_2191">Cheong</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2192">JK</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2193"><span data-html-name="surname" data-name="OPT_ID_2194">Nguyen</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2195">TH</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2196"><span data-html-name="surname" data-name="OPT_ID_2197">Wang</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2198">H</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2199">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2200">IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1<span data-html-name="unicode-char">δ</span>/<span data-html-name="unicode-char">ε</span> and Wnt/<span data-html-name="unicode-char">β</span>-catenin independent inhibition of mitotic spindle formation</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2201">Oncogene</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2202">2011</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2203">30</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2204">22</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2205">2558</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_2206">2569</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2207" data-attr-id="B57" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2208">57.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2209" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2210" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2211"><span data-html-name="surname" data-name="OPT_ID_2212">Choi</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2213">MY</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2214"><span data-html-name="surname" data-name="OPT_ID_2215">Widhopf</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2216">GF</span><span data-html-name="unknown"> </span><span data-html-name="suffix" data-name="OPT_ID_2217">II</span><span data-html-name="prefix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2218"><span data-html-name="surname" data-name="OPT_ID_2219">Wu</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2220">CC</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2221">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2222">Pre-clinical specificity and safety of UC-961, a first-in-class monoclonal antibody targeting ROR1</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2223">Clin Lymphoma Myeloma Leuk</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2224">2015</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2225">15</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2226">suppl</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2227">S167</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_2228">S169</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2229" data-attr-id="B58" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2230">58.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2231" data-attr-publication-type="journal" data-structure="unparsed"><span data-html-name="authors" data-name="OPT_ID_2232" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2233"><span data-html-name="surname" data-name="OPT_ID_2234">Cui</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2235">B</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2236"><span data-html-name="surname" data-name="OPT_ID_2237">Widhopf</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2238">GF</span><span data-html-name="unknown"> </span><span data-html-name="suffix" data-name="OPT_ID_2239">II</span><span data-html-name="prefix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2240"><span data-html-name="surname" data-name="OPT_ID_2241">Prussak</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2242">CE</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2243">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2244">Cirmtuzumab vedotin (UC-961ADC3), an anti-ROR1-monomethyl auristatin E antibody-drug conjugate, is a potential treatment for ROR1-positive leukemia and solid tumors [abstract]</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2245">Blood</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2246">2013</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2247">122</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2248">21</span><span data-html-name="unknown">):1637.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="first-page"></span><span data-html-name="last-page"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2249" data-attr-id="B59" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2250">59.</span><span data-html-name="reference" data-publication-type="other" data-name="OPT_ID_2251" data-attr-publication-type="other" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2252" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2253"><span data-html-name="surname" data-name="OPT_ID_2254">Mani</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2255">R</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2256"><span data-html-name="surname" data-name="OPT_ID_2257">Chiang</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2258">CL</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2259"><span data-html-name="surname" data-name="OPT_ID_2260">Frissora</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2261">FW</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2262">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2263">ROR1-targeted delivery of OSU-2S, a nonimmunosuppressive FTY720 derivative, exerts potent cytotoxicity in mantle-cell lymphoma in vitro and in vivo</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2264">Exp Hematol</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2265">2015</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2266">43</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2267">9</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2268">770</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_2269">774</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2270" data-attr-id="B60" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2271">60.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2272" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2273" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2274"><span data-html-name="surname" data-name="OPT_ID_2275">Zhang</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2276">S</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2277"><span data-html-name="surname" data-name="OPT_ID_2278">Cui</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2279">B</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2280"><span data-html-name="surname" data-name="OPT_ID_2281">Lai</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2282">H</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2283">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2284">Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2285">Proc Natl Acad Sci USA</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2286">2014</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2287">111</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2288">48</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2289">17266</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_2290">17271</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2291" data-attr-id="B61" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2292">61.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2293" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2294" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2295"><span data-html-name="surname" data-name="OPT_ID_2296">Hojjat-Farsangi</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2297">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2298"><span data-html-name="surname" data-name="OPT_ID_2299">Ghaemimanesh</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2300">F</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2301"><span data-html-name="surname" data-name="OPT_ID_2302">Daneshmanesh</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2303">AH</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2304">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2305">Inhibition of the receptor tyrosine kinase ROR1 by anti-ROR1 monoclonal antibodies and siRNA induced apoptosis of melanoma cells</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2306">PLoS One</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2307">2013</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2308">8</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2309">4</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2310">e61167</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="last-page"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2311" data-attr-id="B62" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2312">62.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2313" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2314" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2315"><span data-html-name="surname" data-name="OPT_ID_2316">Berger</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2317">C</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2318"><span data-html-name="surname" data-name="OPT_ID_2319">Sommermeyer</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2320">D</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2321"><span data-html-name="surname" data-name="OPT_ID_2322">Hudecek</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2323">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2324">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2325">Safety of targeting ROR1 in primates with chimeric antigen receptor-modified T cells</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2326">Cancer Immunol Res</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2327">2015</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2328">3</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2329">2</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2330">206</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_2331">216</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2332" data-attr-id="B63" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2333">63.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2334" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2335" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2336"><span data-html-name="surname" data-name="OPT_ID_2337">Eichhorst</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2338">B</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2339"><span data-html-name="surname" data-name="OPT_ID_2340">Hallek</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2341">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2342"><span data-html-name="surname" data-name="OPT_ID_2343">Goede</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2344">V</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="collaboration"></span><span data-html-name="etal"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2345">New treatment approaches in CLL: challenges and opportunities in the elderly</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2346">J Geriatr Oncol</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2347">2016</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2348">7</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2349">5</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2350">375</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_2351">382</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2352" data-attr-id="B64" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2353">64.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2354" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2355" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2356"><span data-html-name="surname" data-name="OPT_ID_2357">Gentile</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2358">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2359"><span data-html-name="surname" data-name="OPT_ID_2360">Petrungaro</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2361">A</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2362"><span data-html-name="surname" data-name="OPT_ID_2363">Uccello</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2364">G</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2365">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2366">Venetoclax for the treatment of chronic lymphocytic leukemia</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2367">Expert Opin Investig Drugs</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2368">2017</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2369">26</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2370">11</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2371">1307</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_2372">1316</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2373" data-attr-id="B65" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2374">65.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2375" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2376" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2377"><span data-html-name="surname" data-name="OPT_ID_2378">de Weerdt</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2379">I</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2380"><span data-html-name="surname" data-name="OPT_ID_2381">Koopmans</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2382">SM</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2383"><span data-html-name="surname" data-name="OPT_ID_2384">Kater</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2385">AP</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2386"><span data-html-name="surname" data-name="OPT_ID_2387">van Gelder</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2388">M</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="collaboration"></span><span data-html-name="etal"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2389">Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2390">Haematologica</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2391">2017</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2392">102</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2393">10</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2394">1629</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_2395">1639</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2396" data-attr-id="B66" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2397">66.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2398" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2399" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2400"><span data-html-name="surname" data-name="OPT_ID_2401">Wu</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2402">J</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2403"><span data-html-name="surname" data-name="OPT_ID_2404">Liu</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2405">C</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2406"><span data-html-name="surname" data-name="OPT_ID_2407">Tsui</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2408">ST</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2409"><span data-html-name="surname" data-name="OPT_ID_2410">Liu</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2411">D</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="collaboration"></span><span data-html-name="etal"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2412">Second-generation inhibitors of Bruton tyrosine kinase</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2413">J Hematol Oncol</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2414">2016</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2415">9</span><span data-html-name="unknown">:</span><span data-html-name="first-page" data-name="OPT_ID_2416">80</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="issue-nr"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="last-page"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2417" data-attr-id="B67" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2418">67.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2419" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2420" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2421"><span data-html-name="surname" data-name="OPT_ID_2422">Arey</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2423">R</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2424"><span data-html-name="surname" data-name="OPT_ID_2425">McClung</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2426">CA</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="collaboration"></span><span data-html-name="etal"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2427">An inhibitor of casein kinase 1 <span data-html-name="unicode-char">ε</span>/<span data-html-name="unicode-char">δ</span> partially normalizes the manic-like behaviors of the Clock<span data-html-name="unicode-char">Δ</span>19 mouse</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2428">Behav Pharmacol</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2429">2012</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2430">23</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2431">4</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2432">392</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_2433">396</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2434" data-attr-id="B68" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2435">68.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2436" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2437" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2438"><span data-html-name="surname" data-name="OPT_ID_2439">Deng</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2440">C</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2441"><span data-html-name="surname" data-name="OPT_ID_2442">Lipstein</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2443">MR</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2444"><span data-html-name="surname" data-name="OPT_ID_2445">Scotto</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2446">L</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2447">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2448">Silencing c-Myc translation as a therapeutic strategy through targeting PI3K<span data-html-name="unicode-char">δ</span> and CK1<span data-html-name="unicode-char">ε</span> in hematological malignancies</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2449">Blood</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2450">2017</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2451">129</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2452">1</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2453">88</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_2454">99</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2455" data-attr-id="B69" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2456">69.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2457" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2458" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2459"><span data-html-name="surname" data-name="OPT_ID_2460">Gopal</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2461">AK</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2462"><span data-html-name="surname" data-name="OPT_ID_2463">Kahl</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2464">BS</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2465"><span data-html-name="surname" data-name="OPT_ID_2466">de Vos</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2467">S</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2468">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2469">PI3K<span data-html-name="unicode-char">δ</span> inhibition by idelalisib in patients with relapsed indolent lymphoma</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2470">N Engl J Med</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2471">2014</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2472">370</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2473">11</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2474">1008</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_2475">1018</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2476" data-attr-id="B70" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2477">70.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2478" data-attr-publication-type="journal" data-structure="unparsed"><span data-html-name="authors" data-name="OPT_ID_2479" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2480"><span data-html-name="surname" data-name="OPT_ID_2481">O<span data-html-name="unicode-char">’</span>Connor</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2482">OA</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2483"><span data-html-name="surname" data-name="OPT_ID_2484">Flinn</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2485">IW</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2486"><span data-html-name="surname" data-name="OPT_ID_2487">Patel</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2488">MR</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2489">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2490">TGR-1202, a novel once daily PI3K-delta inhibitor, demonstrates clinical activity with a favorable safety profile in patients with CLL and B-cell lymphoma [abstract]</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2491">Blood</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2492">2015</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2493">126</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2494">23</span><span data-html-name="unknown">):4145.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="first-page"></span><span data-html-name="last-page"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2495" data-attr-id="B71" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2496">71.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2497" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2498" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2499"><span data-html-name="surname" data-name="OPT_ID_2500">Robak</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2501">T</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="collaboration"></span><span data-html-name="etal"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2502">Will combination therapy with targeted drugs be better for achieving remission in chronic lymphocytic leukemia?</span><span data-html-name="unknown"> </span><span data-html-name="journal-title" data-name="OPT_ID_2503">Expert Opin Pharmacother</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2504">2017</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2505">18</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2506">16</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2507">1675</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_2508">1678</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li><li data-html-name="bibliography-reference" data-name="OPT_ID_2509" data-attr-id="B72" data-meta-info="reference:mixed-citation author:string-name editor:string-name" data-para="true"><span data-html-name="bibliography-reference-label" data-name="OPT_ID_2510">72.</span><span data-html-name="reference" data-publication-type="journal" data-name="OPT_ID_2511" data-attr-publication-type="journal" data-structure="parsed"><span data-html-name="authors" data-name="OPT_ID_2512" data-attr-person-group-type="author"><span data-html-name="author" data-name="OPT_ID_2513"><span data-html-name="surname" data-name="OPT_ID_2514">Byrd</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2515">JC</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2516"><span data-html-name="surname" data-name="OPT_ID_2517">Furman</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2518">RR</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="author" data-name="OPT_ID_2519"><span data-html-name="surname" data-name="OPT_ID_2520">Coutre</span><span data-html-name="unknown"> </span><span data-html-name="given-name" data-name="OPT_ID_2521">SE</span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="unknown">, </span><span data-html-name="etal" data-name="OPT_ID_2522">et al</span><span data-html-name="collaboration"></span><span data-html-name="ellipses"></span></span><span data-html-name="unknown">. </span><span data-html-name="article-title" data-name="OPT_ID_2523">Three-year follow-up of treatment-na<span data-html-name="unicode-char">ï</span>ve and previously treated patients with CLL and SLL receiving single-agent ibrutinib</span><span data-html-name="unknown">. </span><span data-html-name="journal-title" data-name="OPT_ID_2524">Blood</span><span data-html-name="unknown">. </span><span data-html-name="year" data-name="OPT_ID_2525">2015</span><span data-html-name="unknown">;</span><span data-html-name="volume-nr" data-name="OPT_ID_2526">125</span><span data-html-name="unknown">(</span><span data-html-name="issue-nr" data-name="OPT_ID_2527">16</span><span data-html-name="unknown">):</span><span data-html-name="first-page" data-name="OPT_ID_2528">2497</span><span data-html-name="unknown">-</span><span data-html-name="last-page" data-name="OPT_ID_2529">2506</span><span data-html-name="unknown">.</span><span data-html-name="reference-label"></span><span data-html-name="translated-article-title"></span><span data-html-name="editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="issue-title"></span><span data-html-name="translated-issue-title"></span><span data-html-name="supplement"></span><span data-html-name="translated-journal-title"></span><span data-html-name="book-title"></span><span data-html-name="translated-book-title"></span><span data-html-name="edited-book-title"></span><span data-html-name="translated-edited-book-title"></span><span data-html-name="conference-unstructured"></span><span data-html-name="conference-acronym"></span><span data-html-name="conference-date"></span><span data-html-name="conference-location"></span><span data-html-name="conference-name"></span><span data-html-name="conference-sponsor"></span><span data-html-name="issn"></span><span data-html-name="chapter-title"></span><span data-html-name="translated-chapter-title"></span><span data-html-name="book-series-title"></span><span data-html-name="translated-book-series-title"></span><span data-html-name="edition"></span><span data-html-name="series-editors"><span data-html-name="editor"><span data-html-name="surname"></span><span data-html-name="given-name"></span><span data-html-name="prefix"></span><span data-html-name="suffix"></span></span><span data-html-name="etal"></span></span><span data-html-name="publisher-name"></span><span data-html-name="publisher-location"></span><span data-html-name="isbn"></span><span data-html-name="ref-article-number"></span><span data-html-name="doi"></span><span data-html-name="comment"></span><span data-html-name="pmid"></span></span></li></ul></div></div></section></section><div data-html-name="back-matter" data-name="OPT_ID_1023" data-para="true"></div></article></body></html>
